Metabolic	O
and	O
ultrastructural	O
aspects	O
of	O
the	O
in	O
vitro	O
lysis	O
of	O
chronic	B-cell_type
lymphocytic	I-cell_type
leukemia	I-cell_type
cells	I-cell_type
by	O
glucocorticoids	O
.	O

Human	B-cell_type
chronic	I-cell_type
lymphocytic	I-cell_type
leukemia	I-cell_type
(	I-cell_type
CLL	I-cell_type
)	I-cell_type
cells	I-cell_type
like	O
prothymocytes	B-cell_type
and	O
immunoactivated	B-cell_type
T-lymphocytes	I-cell_type
are	O
readily	O
lysed	O
in	O
vitro	O
by	O
pharmacological	O
concentrations	O
of	O
glucocorticoids	O
such	O
as	O
cortisol	O
,	O
whereas	O
peripheral	B-cell_type
blood	I-cell_type
lymphocytes	I-cell_type
and	O
thymocytes	B-cell_type
are	O
unaffected	O
by	O
the	O
hormone	B-protein
.	O

In	O
this	O
study	O
,	O
metabolic	O
and	O
ultrastructural	O
aspects	O
of	O
the	O
cortisol-induced	O
killing	O
process	O
of	O
CLL	B-cell_type
cells	I-cell_type
are	O
recorded	O
.	O

In	O
vitro	O
lysis	O
was	O
found	O
to	O
be	O
temperature	O
dependent	O
and	O
was	O
detected	O
only	O
after	O
6	O
to	O
8	O
hr	O
incubation	O
with	O
cortisol	O
by	O
means	O
of	O
the	O
trypan	O
blue	O
exclusion	O
test	O
.	O

However	O
,	O
30	O
min	O
of	O
incubation	O
with	O
cortisol	O
at	O
either	O
37	O
degrees	O
or	O
4	O
degrees	O
followed	O
by	O
the	O
removal	O
of	O
the	O
hormone	B-protein
was	O
still	O
sufficient	O
to	O
induce	O
the	O
lytic	O
process	O
.	O

Ultrastructural	O
studies	O
demonstrated	O
sequential	O
changes	O
in	O
the	O
cytoplasm	O
,	O
including	O
swelling	O
of	O
mitochondria	O
and	O
cytoplasmic	O
decompartmentalization	O
,	O
followed	O
by	O
loss	O
of	O
surface	O
microvilli	O
with	O
the	O
appearance	O
of	O
``	O
holes	O
''	O
in	O
the	O
cell	O
membrane	O
,	O
and	O
subsequent	O
condensation	O
of	O
nuclear	B-DNA
chromatin	I-DNA
.	O

The	O
large	O
holes	O
in	O
the	O
membrane	O
appearing	O
after	O
6	O
hr	O
of	O
incubation	O
with	O
the	O
hormone	B-protein
may	O
be	O
the	O
cause	O
for	O
the	O
penetration	O
of	O
the	O
viable	O
stain	O
into	O
the	O
dead	B-cell_type
cells	I-cell_type
,	O
as	O
seen	O
by	O
light	O
microscopy	O
.	O

Addition	O
of	O
metabolic	O
inhibitors	O
including	O
actinomycin	O
D	O
,	O
puromycin	O
,	O
and	O
cycloheximide	O
following	O
administration	O
of	O
cortisol	O
resulted	O
in	O
inhibition	O
of	O
the	O
cell	O
lysis	O
.	O

An	O
excess	O
of	O
an	O
antagonist	O
such	O
as	O
cortexolone	O
was	O
found	O
to	O
inhibit	O
the	O
cortisol-induced	O
cytolysis	O
of	O
the	O
CLL	B-cell_line
cells	I-cell_line
.	O

It	O
is	O
suggested	O
that	O
the	O
glucocorticoid-induced	O
lysis	O
of	O
human	B-cell_line
CLL	I-cell_line
cells	I-cell_line
is	O
similar	O
to	O
the	O
phenomenon	O
observed	O
in	O
rat	B-cell_type
or	I-cell_type
murine	I-cell_type
lymphocytes	I-cell_type
and	O
is	O
mediated	O
by	O
interaction	O
of	O
the	O
steroid	O
molecule	O
with	O
the	O
cytoplasmic	B-protein
receptor	I-protein
.	O

The	O
resulting	O
complex	O
appears	O
to	O
activate	O
specific	O
gene	B-DNA
(	O
s	O
)	O
the	O
products	O
of	O
which	O
eventually	O
cause	O
cytolysis	O
.	O

[	NULL
CANCER	NULL
RESEARCH	NULL
42	NULL
,	NULL
1433-1440	NULL
,	NULL
April	NULL
1982	NULL
]	NULL
0008-5472/82/0042-0000	NULL
$	NULL
02.00	NULL
Metabolic	NULL
and	NULL
Ultrastructural	NULL
Aspects	NULL
of	NULL
the	NULL
in	NULL
Vitro	NULL
Lysis	NULL
of	NULL
Chronic	NULL
Lymphocytic	NULL
Leukemia	NULL
Cells	NULL
by	NULL
Glucocorticoids	NULL
'	NULL
Uri	NULL
Galili	NULL
,	NULL
*	NULL
Rachel	NULL
Leizerowitz	NULL
,	NULL
Jan	NULL
Moreb	NULL
,	NULL
Haim	NULL
Gamliel	NULL
,	NULL
Dorit	NULL
Gurfel	NULL
,	NULL
and	NULL
Aaron	NULL
Polliack	NULL
Department	NULL
of	NULL
Hematology	NULL
,	NULL
Hadassah	NULL
University	NULL
Hospital	NULL
,	NULL
Jerusalem	NULL
,	NULL
Israel	NULL
ABSTRACT	NULL
Human	NULL
chronic	NULL
lymphocytic	NULL
leukemia	NULL
(	NULL
CLL	NULL
)	NULL
cells	NULL
like	NULL
prothymocytes	NULL
and	NULL
immunoactivated	NULL
T-lymphocytes	NULL
are	NULL
readily	NULL
lysed	NULL
in	NULL
vitro	NULL
by	NULL
pharmacological	NULL
concentrations	NULL
of	NULL
glucocorticoids	NULL
such	NULL
as	NULL
cortisol	NULL
,	NULL
whereas	NULL
peripae	NULL
.	NULL

al	NULL
blood	NULL
lymphocytes	NULL
and	NULL
thymocytes	NULL
are	NULL
unaffected	NULL
by	NULL
ithe	NULL
hormone	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
metabolic	NULL
and	NULL
ultrastructural	NULL
aspects	NULL
of	NULL
the	NULL
cortisol-induced	NULL
killing	NULL
process	NULL
of	NULL
CLL	NULL
cells	NULL
are	NULL
recorded	NULL
.	NULL

in	NULL
vitro	NULL
lysis	NULL
was	NULL
found	NULL
to	NULL
be	NULL
temperature	NULL
dependent	NULL
and	NULL
was	NULL
detected	NULL
only	NULL
after	NULL
6	NULL
to	NULL
8	NULL
hr	NULL
incubation	NULL
with	NULL
cortisol	NULL
by	NULL
means	NULL
of	NULL
the	NULL
trypan	NULL
blue	NULL
exclusion	NULL
test	NULL
.	NULL

However	NULL
,	NULL
30	NULL
min	NULL
of	NULL
incubation	NULL
with	NULL
cortisol	NULL
at	NULL
either	NULL
37°	NULL
or	NULL
4°	NULL
followed	NULL
by	NULL
the	NULL
removal	NULL
of	NULL
the	NULL
hormone	NULL
was	NULL
still	NULL
sufficient	NULL
to	NULL
induce	NULL
the	NULL
lytic	NULL
process	NULL
.	NULL

Ultrastructural	NULL
studies	NULL
demonstrated	NULL
sequential	NULL
changes	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
including	NULL
swelling	NULL
of	NULL
mitochondria	NULL
and	NULL
cytoplasmic	NULL
decompartmentali-zation	NULL
,	NULL
followed	NULL
by	NULL
loss	NULL
of	NULL
surface	NULL
microvilli	NULL
with	NULL
the	NULL
appearance	NULL
of	NULL
``	NULL
holes	NULL
``	NULL
in	NULL
the	NULL
cell	NULL
membrane	NULL
,	NULL
and	NULL
subsequent	NULL
condensation	NULL
of	NULL
nuclear	NULL
chromatin	NULL
.	NULL

The	NULL
large	NULL
holes	NULL
in	NULL
the	NULL
membrane	NULL
appearing	NULL
after	NULL
6	NULL
hr	NULL
of	NULL
incubation	NULL
with	NULL
the	NULL
hormone	NULL
may	NULL
be	NULL
the	NULL
cause	NULL
for	NULL
the	NULL
penetration	NULL
of	NULL
the	NULL
viable	NULL
stain	NULL
into	NULL
the	NULL
dead	NULL
cells	NULL
,	NULL
as	NULL
seen	NULL
by	NULL
light	NULL
microscopy	NULL
.	NULL

Addition	NULL
of	NULL
metabolic	NULL
inhibitors	NULL
including	NULL
actinomycin	NULL
D	NULL
,	NULL
puromycin	NULL
,	NULL
and	NULL
cycloheximide	NULL
following	NULL
administration	NULL
of	NULL
cortisol	NULL
resulted	NULL
in	NULL
inhibition	NULL
of	NULL
the	NULL
cell	NULL
lysis	NULL
.	NULL

An	NULL
excess	NULL
of	NULL
an	NULL
antagonist	NULL
such	NULL
as	NULL
cortexolone	NULL
was	NULL
found	NULL
to	NULL
inhibit	NULL
the	NULL
cortisol-induced	NULL
cytolysis	NULL
of	NULL
the	NULL
CLL	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
suggested	NULL
that	NULL
the	NULL
glucocorticoid-induced	NULL
lysis	NULL
of	NULL
human	NULL
CLL	NULL
cells	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
phenomenon	NULL
observed	NULL
in	NULL
rat	NULL
or	NULL
murine	NULL
lymphocytes	NULL
and	NULL
is	NULL
mediated	NULL
by	NULL
interaction	NULL
of	NULL
the	NULL
steroid	NULL
molecule	NULL
with	NULL
the	NULL
cytoplasmic	NULL
receptor	NULL
.	NULL

The	NULL
resulting	NULL
complex	NULL
appears	NULL
to	NULL
activate	NULL
specific	NULL
gene	NULL
(	NULL
s	NULL
)	NULL
the	NULL
products	NULL
of	NULL
which	NULL
eventually	NULL
cause	NULL
cytolysis	NULL
.	NULL

INTRODUCTION	NULL
GC	NULL
``	NULL
induce	NULL
an	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
cytolytic	NULL
effect	NULL
on	NULL
murine	NULL
and	NULL
rat	NULL
thymocytes	NULL
and	NULL
peripheral	NULL
lymphocytes	NULL
.	NULL

However	NULL
,	NULL
these	NULL
hormones	NULL
do	NULL
not	NULL
affect	NULL
viability	NULL
of	NULL
the	NULL
same	NULL
human	NULL
cells	NULL
in	NULL
vitro	NULL
(	NULL
2	NULL
,	NULL
3	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
have	NULL
described	NULL
the	NULL
sensitivity	NULL
of	NULL
subpopulations	NULL
of	NULL
lymphoid	NULL
cells	NULL
including	NULL
human	NULL
prothymocytes	NULL
and	NULL
activated	NULL
T-lymphocytes	NULL
(	NULL
8-11	NULL
)	NULL
to	NULL
GC-induced	NULL
cytolysis	NULL
.	NULL

Several	NULL
types	NULL
of	NULL
leukemic	NULL
lymphocytes	NULL
were	NULL
also	NULL
readily	NULL
lysed	NULL
in	NULL
vitro	NULL
by	NULL
pharmacological	NULL
concentrations	NULL
of	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
awarded	NULL
by	NULL
the	NULL
Israel	NULL
Cancer	NULL
Research	NULL
Fund	NULL
,	NULL
the	NULL
Israeli	NULL
National	NULL
Academy	NULL
of	NULL
Science	NULL
,	NULL
the	NULL
Joint	NULL
Research	NULL
Fund	NULL
of	NULL
the	NULL
Hebrew	NULL
University	NULL
and	NULL
Hadassah	NULL
,	NULL
the	NULL
Lady	NULL
Davis	NULL
Fellowship	NULL
,	NULL
the	NULL
United	NULL
States-Israel	NULL
Binational	NULL
Science	NULL
Foundation	NULL
(	NULL
BSF	NULL
)	NULL
,	NULL
Jerusalem	NULL
,	NULL
Israel	NULL
.	NULL

*	NULL
To	NULL
whom	NULL
requests	NULL
for	NULL
reprints	NULL
should	NULL
be	NULL
addressed	NULL
,	NULL
at	NULL
Department	NULL
of	NULL
Hematology	NULL
,	NULL
Hadassah	NULL
University	NULL
Hospital	NULL
,	NULL
Kiryat	NULL
Hadassah	NULL
,	NULL
P.	NULL
O	NULL
.	NULL

B	NULL
.	NULL

12000	NULL
,	NULL
IL-91	NULL
120	NULL
Jerusalem	NULL
,	NULL
israel	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
GC	NULL
,	NULL
glucocorticoids	NULL
;	NULL
CLL	NULL
,	NULL
chronic	NULL
lymphocytic	NULL
leukemia	NULL
;	NULL
ALL	NULL
,	NULL
Acute	NULL
lymphoblastic	NULL
leukemia	NULL
;	NULL
TEM	NULL
,	NULL
transmission	NULL
electron	NULL
mi-croscopy	NULL
;	NULL
SEM	NULL
,	NULL
scanning	NULL
electron	NULL
microscopy	NULL
.	NULL

Received	NULL
November	NULL
10	NULL
,	NULL
1980	NULL
;	NULL
accepted	NULL
December	NULL
8	NULL
,	NULL
1981	NULL
.	NULL

APRIL	NULL
1982	NULL
cortisol	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
CLL	NULL
and	NULL
some	NULL
ALL	NULL
cells	NULL
were	NULL
sensitive	NULL
,	NULL
whereas	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
and	NULL
other	NULL
ALL	NULL
cell	NULL
populations	NULL
as	NULL
well	NULL
as	NULL
normal	NULL
lymphocytes	NULL
and	NULL
thymocytes	NULL
were	NULL
resistant	NULL
to	NULL
the	NULL
lytic	NULL
effect	NULL
of	NULL
the	NULL
hormone	NULL
in	NULL
vitro	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Studies	NULL
on	NULL
the	NULL
mechanism	NULL
of	NULL
GC-induced	NULL
lympholysis	NULL
of	NULL
rodent	NULL
thymocytes	NULL
or	NULL
lymphoma	NULL
cells	NULL
have	NULL
shown	NULL
that	NULL
specific	NULL
cytoplasmic	NULL
receptors	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
process	NULL
of	NULL
killing	NULL
(	NULL
6	NULL
,	NULL
18	NULL
,	NULL
21	NULL
,	NULL
25	NULL
,	NULL
27	NULL
)	NULL
.	NULL

It	NULL
appears	NULL
that	NULL
the	NULL
steroid	NULL
molecule	NULL
rapidly	NULL
penetrates	NULL
through	NULL
the	NULL
cell	NULL
membrane	NULL
and	NULL
interacts	NULL
with	NULL
specific	NULL
cytoplasmic	NULL
receptors	NULL
.	NULL

Thereafter	NULL
,	NULL
the	NULL
complex	NULL
penetrates	NULL
into	NULL
the	NULL
nucleus	NULL
,	NULL
binds	NULL
to	NULL
the	NULL
chromatin	NULL
,	NULL
and	NULL
activates	NULL
certain	NULL
genes	NULL
.	NULL

The	NULL
subsequent	NULL
gene	NULL
product	NULL
(	NULL
s	NULL
)	NULL
synthesized	NULL
eventually	NULL
causes	NULL
cell	NULL
death	NULL
(	NULL
15	NULL
,	NULL
22	NULL
)	NULL
.	NULL

The	NULL
purpose	NULL
of	NULL
the	NULL
present	NULL
study	NULL
was	NULL
to	NULL
record	NULL
various	NULL
aspects	NULL
of	NULL
the	NULL
in	NULL
vitro	NULL
GC-induced	NULL
cytolysis	NULL
of	NULL
human	NULL
leukemic	NULL
cells	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
CLL	NULL
cells	NULL
were	NULL
used	NULL
as	NULL
targets	NULL
,	NULL
and	NULL
the	NULL
metabolic	NULL
and	NULL
morphological	NULL
events	NULL
occurring	NULL
in	NULL
the	NULL
course	NULL
of	NULL
lysis	NULL
were	NULL
studied	NULL
.	NULL

The	NULL
data	NULL
obtained	NULL
from	NULL
these	NULL
experiments	NULL
suggest	NULL
that	NULL
GC-induced	NULL
lysis	NULL
of	NULL
CLL	NULL
cells	NULL
is	NULL
mediated	NULL
by	NULL
intracellular	NULL
events	NULL
similar	NULL
to	NULL
those	NULL
occurring	NULL
in	NULL
GC-sensitive	NULL
rodent	NULL
lymphoid	NULL
cell	NULL
populations	NULL
.	NULL

Furthermore	NULL
,	NULL
ultrastructural	NULL
observations	NULL
show	NULL
sequential	NULL
changes	NULL
in	NULL
the	NULL
cytoplasm	NULL
and	NULL
subsequently	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
,	NULL
which	NULL
precede	NULL
actual	NULL
cell	NULL
death	NULL
by	NULL
several	NULL
hr	NULL
.	NULL

All	NULL
studies	NULL
for	NULL
analyzing	NULL
cell	NULL
lysis	NULL
were	NULL
performed	NULL
at	NULL
the	NULL
pharmacological	NULL
concentration	NULL
2	NULL
x	NULL
10~°	NULL
m	NULL
cortisol	NULL
(	NULL
3	NULL
)	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
CLL	NULL
Lymphocytes	NULL
.	NULL

Cells	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
CLL	NULL
patients	NULL
with	NULL
leukocyte	NULL
counts	NULL
of	NULL
above	NULL
50,000/cu	NULL
mm	NULL
(	NULL
range	NULL
,	NULL
50,000	NULL
to	NULL
350,000	NULL
cells/cu	NULL
mm	NULL
)	NULL
.	NULL

The	NULL
lymphocytes	NULL
were	NULL
separated	NULL
from	NULL
the	NULL
blood	NULL
by	NULL
gradient	NULL
centrifugation	NULL
using	NULL
Ficoll-Hypaque	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
Roswell	NULL
Park	NULL
Memorial	NULL
Institute	NULL
Medium	NULL
1640	NULL
(	NULL
Grand	NULL
Island	NULL
Biological	NULL
Co.	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
N	NULL
.	NULL

Y	NULL
.	NULL
)	NULL

supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
and	NULL
brought	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
2	NULL
x	NULL
10°	NULL
cells/ml	NULL
.	NULL

In	NULL
Vitro	NULL
GC-induced	NULL
Lympholysis	NULL
.	NULL

This	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
earlier	NULL
studies	NULL
(	NULL
8-12	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
aliquots	NULL
of	NULL
0.2	NULL
mi	NULL
CLL	NULL
cells	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
cells/m	NULL
!	NULL
)	NULL

were	NULL
incubated	NULL
with	NULL
2	NULL
x	NULL
10~°	NULL
m	NULL
cortisol	NULL
(	NULL
Ikapharm	NULL
,	NULL
Ramat	NULL
Gan	NULL
,	NULL
Israel	NULL
)	NULL
in	NULL
flat-bottomed	NULL
microwells	NULL
(	NULL
Cooke	NULL
Engineering	NULL
Co.	NULL
,	NULL
Al-exandria	NULL
,	NULL
Va.	NULL
)	NULL
for	NULL
various	NULL
periods	NULL
of	NULL
time	NULL
(	NULL
1	NULL
to	NULL
20	NULL
hr	NULL
)	NULL
at	NULL
37°	NULL
and	NULL
at	NULL
other	NULL
temperatures	NULL
when	NULL
indicated	NULL
.	NULL

The	NULL
proportion	NULL
of	NULL
lysed	NULL
cells	NULL
was	NULL
assessed	NULL
by	NULL
determining	NULL
the	NULL
concentration	NULL
of	NULL
the	NULL
remaining	NULL
viable	NULL
cells	NULL
in	NULL
a	NULL
hemocytometer	NULL
using	NULL
the	NULL
trypan	NULL
blue	NULL
exclusion	NULL
test	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
cytolysis	NULL
was	NULL
calculated	NULL
by	NULL
means	NULL
of	NULL
the	NULL
formula	NULL
(	NULL
a	NULL
-	NULL
b	NULL
)	NULL
/a	NULL
x	NULL
100	NULL
where	NULL
a	NULL
is	NULL
the	NULL
concentration	NULL
of	NULL
viable	NULL
cells	NULL
in	NULL
control	NULL
wells	NULL
containing	NULL
medium	NULL
without	NULL
cortisol	NULL
and	NULL
b	NULL
is	NULL
the	NULL
concentration	NULL
of	NULL
viable	NULL
cells	NULL
in	NULL
wells	NULL
containing	NULL
the	NULL
hormone	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
other	NULL
steroids	NULL
was	NULL
also	NULL
studied	NULL
.	NULL

For	NULL
all	NULL
electron	NULL
microscopic	NULL
studies	NULL
,	NULL
10-ml	NULL
aliquots	NULL
of	NULL
the	NULL
lymphoid	NULL
suspensions	NULL
were	NULL
incubated	NULL
with	NULL
2	NULL
x	NULL
10~	NULL
``	NULL
m	NULL
cortisol	NULL
at	NULL
37°	NULL
in	NULL
5	NULL
%	NULL
1433	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1982	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

U.	NULL
Galili	NULL
et	NULL
al	NULL
.	NULL

CO	NULL
;	NULL
humidified	NULL
atmosphere	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
at	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
6	NULL
hr	NULL
of	NULL
incubation	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
processed	NULL
for	NULL
electron	NULL
microscopy	NULL
as	NULL
described	NULL
below	NULL
.	NULL

Metabolic	NULL
Inhibitors	NULL
.	NULL

Actinomycin	NULL
D	NULL
(	NULL
0.01	NULL
ug/ml	NULL
;	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Mo	NULL
.	NULL
)	NULL

,	NULL
an	NULL
inhibitor	NULL
of	NULL
RNA	NULL
synthesis	NULL
,	NULL
and	NULL
cycloheximide	NULL
(	NULL
0.1	NULL
ug/ml	NULL
;	NULL
Sigma	NULL
)	NULL
and	NULL
puromycin	NULL
(	NULL
0.1	NULL
ug/ml	NULL
;	NULL
Sigma	NULL
)	NULL
,	NULL
both	NULL
inhibitors	NULL
of	NULL
protein	NULL
synthesis	NULL
,	NULL
were	NULL
used	NULL
to	NULL
determine	NULL
whether	NULL
transcriptional	NULL
and	NULL
translational	NULL
events	NULL
occur	NULL
in	NULL
the	NULL
cells	NULL
in	NULL
the	NULL
course	NULL
of	NULL
GC-induced	NULL
cytolysis	NULL
.	NULL

These	NULL
inhibitors	NULL
were	NULL
added	NULL
to	NULL
the	NULL
cell	NULL
suspensions	NULL
at	NULL
various	NULL
time	NULL
intervals	NULL
after	NULL
administration	NULL
of	NULL
cortisol	NULL
.	NULL

The	NULL
degree	NULL
of	NULL
inhibition	NULL
of	NULL
cortisol-induced	NULL
lysis	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
inhibitor	NULL
was	NULL
measured	NULL
after	NULL
an	NULL
additional	NULL
8-hr	NULL
incubation	NULL
.	NULL

During	NULL
this	NULL
incubation	NULL
period	NULL
,	NULL
the	NULL
metabolic	NULL
inhibitors	NULL
alone	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
viability	NULL
of	NULL
the	NULL
CLL	NULL
cells	NULL
.	NULL

Mortality	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
inhibitor	NULL
alone	NULL
never	NULL
exceeded	NULL
5	NULL
%	NULL
of	NULL
dead	NULL
cells	NULL
(	NULL
trypan	NULL
blue	NULL
exclusion	NULL
)	NULL
.	NULL

TEM	NULL
.	NULL

Cell	NULL
pellets	NULL
(	NULL
6	NULL
to	NULL
8	NULL
x	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
fixed	NULL
with	NULL
phosphate-buffered	NULL
1.25	NULL
%	NULL
glutaraldehyde	NULL
(	NULL
pH	NULL
7.3	NULL
,	NULL
4°	NULL
)	NULL
for	NULL
at	NULL
least	NULL
1	NULL
hr	NULL
,	NULL
rinsed	NULL
with	NULL
0.2	NULL
m	NULL
phosphate	NULL
buffer	NULL
,	NULL
postfixed	NULL
in	NULL
osmium	NULL
tetroxide	NULL
for	NULL
1	NULL
hr	NULL
at	NULL
4°	NULL
,	NULL
dehydrated	NULL
through	NULL
a	NULL
graded	NULL
series	NULL
of	NULL
ethanols	NULL
,	NULL
embedded	NULL
in	NULL
low-viscosity	NULL
epoxy	NULL
resin	NULL
embedding	NULL
medium	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Spiirr	NULL
(	NULL
28	NULL
)	NULL
,	NULL
and	NULL
sectioned	NULL
with	NULL
an	NULL
MT-2	NULL
Porter-Blum	NULL
microtome	NULL
equipped	NULL
with	NULL
a	NULL
diamond	NULL
knife	NULL
.	NULL

Thin	NULL
sections	NULL
were	NULL
mounted	NULL
on	NULL
un-coated	NULL
copper	NULL
grids	NULL
,	NULL
stained	NULL
with	NULL
uranyl	NULL
acetate	NULL
and	NULL
lead	NULL
citrate	NULL
,	NULL
and	NULL
viewed	NULL
with	NULL
a	NULL
Phillips	NULL
EM-300	NULL
electron	NULL
microscope	NULL
.	NULL

SEM	NULL
.	NULL

Six	NULL
million	NULL
cells	NULL
were	NULL
fixed	NULL
in	NULL
suspension	NULL
in	NULL
1	NULL
%	NULL
phosphate-buffered	NULL
glutaraldehyde	NULL
(	NULL
pH	NULL
7.3	NULL
,	NULL
310	NULL
mosmo	NULL
!	NULL
)	NULL

for	NULL
at	NULL
least	NULL
1	NULL
hr	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
then	NULL
collected	NULL
onto	NULL
glass	NULL
coverslips	NULL
covered	NULL
by	NULL
poly-L-lysine	NULL
.	NULL

Coverslips	NULL
with	NULL
monolayers	NULL
of	NULL
cells	NULL
were	NULL
fixed	NULL
for	NULL
1	NULL
hr	NULL
more	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
then	NULL
prepared	NULL
for	NULL
SEM	NULL
by	NULL
further	NULL
dehydration	NULL
in	NULL
a	NULL
graded	NULL
series	NULL
of	NULL
ethanol	NULL
and	NULL
Freon	NULL
113	NULL
,	NULL
and	NULL
critical	NULL
point	NULL
dried	NULL
with	NULL
Freon	NULL
113	NULL
as	NULL
described	NULL
in	NULL
earlier	NULL
studies	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
specimens	NULL
were	NULL
then	NULL
coated	NULL
with	NULL
a	NULL
thin	NULL
layer	NULL
of	NULL
gold-palladium	NULL
and	NULL
examined	NULL
with	NULL
a	NULL
Jeol	NULL
SM-35X	NULL
scanning	NULL
electron	NULL
microscope	NULL
at	NULL
an	NULL
accelerating	NULL
voltage	NULL
of	NULL
35	NULL
to	NULL
39	NULL
kV	NULL
.	NULL

RESULTS	NULL
Effect	NULL
of	NULL
Temperature	NULL
on	NULL
Cortisol-induced	NULL
Cytolysis	NULL
of	NULL
CLL	NULL
Cells	NULL
.	NULL

The	NULL
process	NULL
of	NULL
lysis	NULL
is	NULL
not	NULL
rapid	NULL
and	NULL
can	NULL
be	NULL
detected	NULL
by	NULL
means	NULL
of	NULL
the	NULL
vital	NULL
staining	NULL
technique	NULL
only	NULL
after	NULL
6	NULL
hr	NULL
of	NULL
incubation	NULL
with	NULL
the	NULL
hormone	NULL
at	NULL
37°	NULL
(	NULL
Chart	NULL
1	NULL
)	NULL
.	NULL

Lysis	NULL
peaks	NULL
after	NULL
8	NULL
hr	NULL
of	NULL
incubation	NULL
.	NULL

No	NULL
significant	NULL
increase	NULL
in	NULL
lysis	NULL
was	NULL
detected	NULL
after	NULL
further	NULL
incubation	NULL
for	NULL
periods	NULL
of	NULL
time	NULL
up	NULL
to	NULL
20	NULL
hr	NULL
.	NULL

The	NULL
process	NULL
of	NULL
lysis	NULL
is	NULL
temperature	NULL
dependent	NULL
since	NULL
after	NULL
incubation	NULL
at	NULL
24°	NULL
or	NULL
4°	NULL
the	NULL
cells	NULL
are	NULL
unaffected	NULL
.	NULL

However	NULL
,	NULL
the	NULL
penetration	NULL
of	NULL
the	NULL
hormone	NULL
into	NULL
the	NULL
cells	NULL
followed	NULL
by	NULL
its	NULL
binding	NULL
to	NULL
cytoplasmic	NULL
receptors	NULL
is	NULL
a	NULL
rapid	NULL
process	NULL
which	NULL
is	NULL
temperature	NULL
independent	NULL
.	NULL

Thus	NULL
,	NULL
incubation	NULL
of	NULL
the	NULL
cells	NULL
for	NULL
30	NULL
min	NULL
with	NULL
2	NULL
x	NULL
10~	NULL
``	NULL
m	NULL
cortisol	NULL
at	NULL
37°	NULL
or	NULL
4°	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
removal	NULL
of	NULL
the	NULL
hormone	NULL
from	NULL
the	NULL
medium	NULL
and	NULL
further	NULL
incubation	NULL
of	NULL
the	NULL
cells	NULL
at	NULL
37°	NULL
,	NULL
resulted	NULL
in	NULL
the	NULL
same	NULL
extent	NULL
of	NULL
cell	NULL
lysis	NULL
obtained	NULL
in	NULL
the	NULL
suspensions	NULL
containing	NULL
the	NULL
hormone	NULL
for	NULL
the	NULL
entire	NULL
incubation	NULL
period	NULL
(	NULL
Chart	NULL
1	NULL
)	NULL
.	NULL

Effect	NULL
of	NULL
Metabolic	NULL
Inhibitors	NULL
on	NULL
Cortisol-induced	NULL
Lysis	NULL
.	NULL

From	NULL
the	NULL
results	NULL
of	NULL
this	NULL
study	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
the	NULL
cortisol-induced	NULL
lytic	NULL
process	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
production	NULL
of	NULL
RNA	NULL
and	NULL
protein	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
actinomycin	NULL
D	NULL
together	NULL
with	NULL
the	NULL
hormone	NULL
resulted	NULL
in	NULL
a	NULL
70	NULL
%	NULL
inhibition	NULL
of	NULL
the	NULL
induced	NULL
lysis	NULL
(	NULL
Chart	NULL
2	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
addition	NULL
of	NULL
the	NULL
RNA	NULL
translation	NULL
inhibitors	NULL
cycloheximide	NULL
and	NULL
puromycin	NULL
,	NULL
together	NULL
with	NULL
the	NULL
cortisol	NULL
,	NULL
resulted	NULL
in	NULL
80	NULL
to	NULL
90	NULL
%	NULL
inhibition	NULL
of	NULL
the	NULL
lysis	NULL
observed	NULL
in	NULL
cell	NULL
suspensions	NULL
containing	NULL
the	NULL
hormone	NULL
alone	NULL
.	NULL

However	NULL
,	NULL
when	NULL
the	NULL
actinomycin	NULL
D	NULL
was	NULL
added	NULL
10	NULL
min	NULL
after	NULL
the	NULL
cortisol	NULL
,	NULL
the	NULL
inhibition	NULL
was	NULL
less	NULL
marked	NULL
.	NULL

No	NULL
inhibitory	NULL
effect	NULL
was	NULL
detected	NULL
when	NULL
actinomycin	NULL
D	NULL
1434	NULL
80	NULL
60	NULL
40	NULL
*	NULL
OF	NULL
LYSIS	NULL
HOURS	NULL
OF	NULL
INCUBATION	NULL
Chart	NULL
1	NULL
.	NULL

Cytolysis	NULL
of	NULL
CLL	NULL
cells	NULL
at	NULL
various	NULL
temperatures	NULL
.	NULL

The	NULL
lymphocytes	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
cells/ml	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
2	NULL
x	NULL
10~°	NULL
m	NULL
cortisol	NULL
for	NULL
various	NULL
time	NULL
periods	NULL
.	NULL

Thereafter	NULL
,	NULL
the	NULL
concentration	NULL
of	NULL
the	NULL
viable	NULL
cells	NULL
was	NULL
assessed	NULL
by	NULL
the	NULL
trypan	NULL
blue	NULL
exclusion	NULL
test	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
lysis	NULL
was	NULL
calculated	NULL
by	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

''	NULL
O	NULL
,	NULL
cells	NULL
incubated	NULL
at	NULL
37°	NULL
;	NULL
D	NULL
,	NULL
cells	NULL
incubated	NULL
at	NULL
24°	NULL
;	NULL
A	NULL
,	NULL
cells	NULL
incubated	NULL
at	NULL
4°	NULL
;	NULL
®	NULL
,	NULL
cells	NULL
incubated	NULL
at	NULL
37°	NULL
with	NULL
the	NULL
hormone	NULL
for	NULL
30	NULL
min	NULL
,	NULL
after	NULL
which	NULL
the	NULL
hormone	NULL
was	NULL
removed	NULL
from	NULL
the	NULL
medium	NULL
by	NULL
washing	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
further	NULL
at	NULL
37°	NULL
;	NULL
A	NULL
,	NULL
cells	NULL
incubated	NULL
with	NULL
the	NULL
hormone	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°	NULL
,	NULL
after	NULL
which	NULL
hormone	NULL
was	NULL
removed	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
further	NULL
incubated	NULL
at	NULL
37°	NULL
.	NULL

The	NULL
data	NULL
are	NULL
of	NULL
a	NULL
representative	NULL
experiment	NULL
(	NULL
one	NULL
of	NULL
5	NULL
performed	NULL
with	NULL
similar	NULL
results	NULL
)	NULL
.	NULL

100	NULL
80	NULL
60	NULL
40	NULL
*/	NULL
INHIBITION	NULL
OF	NULL
LYSIS	NULL
20	NULL
T	NULL
u	NULL
v	NULL
y	NULL
v-	NULL
y	NULL
y	NULL
0	NULL
5	NULL
10	NULL
15	NULL
20	NULL
25	NULL
30	NULL
INCUBATION	NULL
WITH	NULL
CORTISOL	NULL
(	NULL
Min	NULL
)	NULL
Chart	NULL
2	NULL
.	NULL

Inhibitory	NULL
effect	NULL
of	NULL
actinomycin	NULL
D	NULL
(	NULL
0.01	NULL
ug/mi	NULL
)	NULL
(	NULL
0	NULL
)	NULL
,	NULL
cycloxheximide	NULL
(	NULL
0.1	NULL
4g	NULL
/ml	NULL
!	NULL
)	NULL

(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
puromycin	NULL
(	NULL
0.1	NULL
ug/ml	NULL
)	NULL
(	NULL
A	NULL
)	NULL
on	NULL
cortisol-induced	NULL
cytolysis	NULL
of	NULL
CLL	NULL
cells	NULL
.	NULL

The	NULL
metabolic	NULL
inhibitors	NULL
were	NULL
added	NULL
at	NULL
various	NULL
time	NULL
intervals	NULL
following	NULL
administration	NULL
of	NULL
cortisol	NULL
,	NULL
and	NULL
the	NULL
cell	NULL
suspensions	NULL
were	NULL
further	NULL
incubated	NULL
for	NULL
8	NULL
hr	NULL
at	NULL
37°	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
inhibition	NULL
of	NULL
lysis	NULL
was	NULL
assessed	NULL
by	NULL
comparing	NULL
the	NULL
lysis	NULL
in	NULL
suspensions	NULL
containing	NULL
the	NULL
hormone	NULL
with	NULL
that	NULL
scored	NULL
in	NULL
suspensions	NULL
containing	NULL
the	NULL
hormone	NULL
and	NULL
the	NULL
inhibitor	NULL
.	NULL

The	NULL
inhibitors	NULL
alone	NULL
were	NULL
found	NULL
not	NULL
to	NULL
cause	NULL
cell	NULL
death	NULL
under	NULL
these	NULL
incubation	NULL
conditions	NULL
.	NULL

Data	NULL
are	NULL
the	NULL
means	NULL
of	NULL
6	NULL
different	NULL
experiments	NULL
.	NULL

was	NULL
added	NULL
to	NULL
cells	NULL
which	NULL
had	NULL
been	NULL
incubated	NULL
with	NULL
cortisol	NULL
for	NULL
20	NULL
min	NULL
or	NULL
more	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
protein	NULL
synthesis	NULL
inhibitors	NULL
failed	NULL
to	NULL
inhibit	NULL
cytolysis	NULL
when	NULL
added	NULL
to	NULL
cell	NULL
suspensions	NULL
which	NULL
had	NULL
been	NULL
incubated	NULL
with	NULL
cortisol	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Ultrastructural	NULL
(	NULL
TEM	NULL
and	NULL
SEM	NULL
)	NULL
Observations	NULL
on	NULL
GC-induced	NULL
Cytolysis	NULL
.	NULL

Generally	NULL
,	NULL
CLL	NULL
tymphocytes	NULL
are	NULL
small	NULL
round	NULL
cells	NULL
(	NULL
7	NULL
to	NULL
8	NULL
um	NULL
in	NULL
diameter	NULL
)	NULL
which	NULL
contain	NULL
a	NULL
nucleus	NULL
that	NULL
comprises	NULL
the	NULL
large	NULL
proportion	NULL
of	NULL
the	NULL
cell	NULL
.	NULL

The	NULL
nuclei	NULL
show	NULL
dense	NULL
areas	NULL
of	NULL
marginated	NULL
heterochromatin	NULL
and	NULL
a	NULL
distinct	NULL
nuclear	NULL
membrane	NULL
.	NULL

The	NULL
cytoplasm	NULL
shows	NULL
a	NULL
moderate	NULL
number	NULL
of	NULL
round	NULL
or	NULL
elongated	NULL
mitochondria	NULL
,	NULL
some	NULL
strands	NULL
of	NULL
endo-plasmic	NULL
reticulum	NULL
,	NULL
and	NULL
numerous	NULL
ribosomes	NULL
,	NULL
some	NULL
of	NULL
which	NULL
are	NULL
clustered	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

TEM	NULL
and	NULL
SEM	NULL
show	NULL
that	NULL
the	NULL
cell	NULL
membrane	NULL
is	NULL
frequently	NULL
villous	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
to	NULL
4	NULL
)	NULL
.	NULL

CLL	NULL
cells	NULL
which	NULL
were	NULL
incubated	NULL
with	NULL
2	NULL
x	NULL
107	NULL
``	NULL
m	NULL
cortisol	NULL
at	NULL
37°	NULL
for	NULL
varying	NULL
time	NULL
periods	NULL
were	NULL
studied	NULL
in	NULL
order	NULL
to	NULL
document	NULL
the	NULL
ultrastructural	NULL
changes	NULL
occurring	NULL
during	NULL
cell	NULL
death	NULL
.	NULL

Although	NULL
visible	NULL
lysis	NULL
of	NULL
the	NULL
cells	NULL
could	NULL
be	NULL
detected	NULL
only	NULL
after	NULL
6	NULL
hr	NULL
of	NULL
incubation	NULL
with	NULL
the	NULL
hormone	NULL
(	NULL
Chart	NULL
1	NULL
)	NULL
,	NULL
early	NULL
changes	NULL
resulting	NULL
from	NULL
the	NULL
cytolytic	NULL
process	NULL
were	NULL
seen	NULL
after	NULL
2	NULL
hr	NULL
(	NULL
Figs	NULL
.	NULL

5	NULL
to	NULL
8	NULL
)	NULL
.	NULL

No	NULL
distinct	NULL
CANCER	NULL
RESEARCH	NULL
VOL	NULL
.	NULL

42	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1982	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

GC	NULL
Cytolysis	NULL
of	NULL
Leukemic	NULL
Cells	NULL
Table	NULL
1	NULL
Ultrastructural	NULL
changes	NULL
in	NULL
CLL	NULL
cells	NULL
during	NULL
the	NULL
course	NULL
of	NULL
GC-induced	NULL
cell	NULL
lysis	NULL
This	NULL
experiment	NULL
is	NULL
representative	NULL
of	NULL
3	NULL
experiments	NULL
with	NULL
reproducible	NULL
results	NULL
.	NULL

Morphological	NULL
features	NULL
(	NULL
%	NULL
of	NULL
cells	NULL
)	NULL
TEM-	NULL
-	NULL
SEM	NULL
Condensed	NULL
Duration	NULL
of	NULL
incubation	NULL
Cytoplas-	NULL
-	NULL
nuclear	NULL
_	NULL
Holes	NULL
in	NULL
Cells	NULL
Holes	NULL
in	NULL
with	NULL
2	NULL
x	NULL
107	NULL
``	NULL
m	NULL
Normal	NULL
mic	NULL
chroma-	NULL
-	NULL
the	NULL
mem-	NULL
-	NULL
with	NULL
mi-	NULL
_	NULL
``	NULL
Smooth	NULL
``	NULL
-	NULL
the	NULL
mem-	NULL
cortisol	NULL
(	NULL
hr	NULL
)	NULL
cells	NULL
changes	NULL
tin	NULL
brane	NULL
crovilli	NULL
cells	NULL
brane	NULL
0	NULL
93	NULL
5	NULL
1	NULL
1	NULL
99	NULL
0	NULL
1	NULL
2	NULL
60	NULL
27	NULL
12	NULL
1	NULL
84	NULL
15	NULL
1	NULL
4	NULL
30	NULL
36	NULL
26	NULL
8	NULL
52	NULL
36	NULL
12	NULL
6	NULL
22	NULL
17	NULL
15	NULL
46	NULL
31	NULL
40	NULL
29	NULL
6	NULL
(	NULL
control	NULL
)	NULL
``	NULL
90	NULL
6	NULL
3	NULL
1	NULL
97	NULL
3	NULL
1	NULL
*	NULL
Cells	NULL
incubated	NULL
without	NULL
the	NULL
hormone	NULL
.	NULL

alterations	NULL
were	NULL
evident	NULL
in	NULL
the	NULL
nucleus	NULL
,	NULL
but	NULL
cytoplasmic	NULL
100	NULL
CLL	NULL
Normal	NULL
PBL	NULL
changes	NULL
were	NULL
seen	NULL
.	NULL

The	NULL
ribosomes	NULL
lost	NULL
their	NULL
clustered	NULL
appearance	NULL
and	NULL
were	NULL
scattered	NULL
homogeneously	NULL
throughout	NULL
the	NULL
-	NULL
1	NULL
»	NULL
80	NULL
cytoplasm	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
cytoplasmic	NULL
``	NULL
compartmentali-	NULL
-	NULL
i	NULL
zation	NULL
``	NULL
and	NULL
organization	NULL
were	NULL
disturbed	NULL
(	NULL
Figs	NULL
.	NULL

5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
7	NULL
;	NULL
69	NULL
mitochondria	NULL
became	NULL
more	NULL
rounded	NULL
and	NULL
swollen	NULL
,	NULL
but	NULL
their	NULL
°\°	NULL
cristae	NULL
were	NULL
still	NULL
preserved	NULL
.	NULL

The	NULL
surface	NULL
microvilli	NULL
of	NULL
many	NULL
cells	NULL
40	NULL
disappeared	NULL
,	NULL
and	NULL
these	NULL
cells	NULL
showed	NULL
smooth	NULL
surfaces	NULL
(	NULL
Figs	NULL
.	NULL

7	NULL
20	NULL
and	NULL
8	NULL
)	NULL
.	NULL

After	NULL
4	NULL
hr	NULL
of	NULL
incubation	NULL
with	NULL
cortisol	NULL
,	NULL
cells	NULL
showed	NULL
more	NULL
obvious	NULL
changes	NULL
.	NULL

Distinct	NULL
alterations	NULL
were	NULL
seen	NULL
in	NULL
the	NULL
nuclei	NULL
16	NULL
``	NULL
16°	NULL
k	NULL
1640	NULL
a6	NULL
``	NULL
108	NULL
10°	NULL
16°	NULL
(	NULL
Figs	NULL
.	NULL

9	NULL
and	NULL
10	NULL
;	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Large	NULL
areas	NULL
of	NULL
the	NULL
nuclear	NULL
chromatin	NULL
STEROID	NULL
CONCENTRATION	NULL
STEROID	NULL
CONCENTRATION	NULL
became	NULL
condensed	NULL
and	NULL
osmiophilic	NULL
,	NULL
but	NULL
the	NULL
nuclear	NULL
membrane	NULL
(	NULL
Mote	NULL
}	NULL
(	NULL
Mole	NULL
)	NULL
was	NULL
still	NULL
retained	NULL
.	NULL

The	NULL
cytoplasm	NULL
became	NULL
more	NULL
homogeneous	NULL
,	NULL
losing	NULL
its	NULL
former	NULL
electron-dense	NULL
appearance	NULL
,	NULL
and	NULL
in	NULL
many	NULL
cells	NULL
vacuoles	NULL
were	NULL
detected	NULL
beneath	NULL
the	NULL
cell	NULL
surface	NULL
.	NULL

These	NULL
vacuoles	NULL
corresponded	NULL
to	NULL
the	NULL
numerous	NULL
small	NULL
pores	NULL
seen	NULL
in	NULL
the	NULL
membrane	NULL
by	NULL
means	NULL
of	NULL
SEM	NULL
(	NULL
Figs	NULL
.	NULL

11	NULL
and	NULL
12	NULL
)	NULL
.	NULL

After	NULL
6	NULL
hr	NULL
of	NULL
incubation	NULL
with	NULL
the	NULL
hormone	NULL
,	NULL
round	NULL
condensed	NULL
nuclei	NULL
contained	NULL
within	NULL
the	NULL
boundaries	NULL
of	NULL
their	NULL
nuclear	NULL
membranes	NULL
were	NULL
frequently	NULL
seen	NULL
in	NULL
most	NULL
of	NULL
the	NULL
cells	NULL
(	NULL
Figs	NULL
.	NULL

13	NULL
,	NULL
14	NULL
,	NULL
and	NULL
17	NULL
)	NULL
.	NULL

Large	NULL
areas	NULL
of	NULL
nuclear	NULL
chromatin	NULL
had	NULL
lost	NULL
their	NULL
osmiophilic	NULL
features	NULL
,	NULL
and	NULL
large	NULL
vacuoles	NULL
were	NULL
seen	NULL
beneath	NULL
the	NULL
cell	NULL
membrane	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
,	NULL
which	NULL
corresponded	NULL
to	NULL
the	NULL
``	NULL
large	NULL
holes	NULL
'	NULL
seen	NULL
in	NULL
the	NULL
cell	NULL
surface	NULL
by	NULL
means	NULL
of	NULL
SEM	NULL
(	NULL
Figs	NULL
.	NULL

15	NULL
and	NULL
16	NULL
;	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Cell	NULL
death	NULL
,	NULL
detected	NULL
by	NULL
viable	NULL
staining	NULL
,	NULL
seems	NULL
to	NULL
be	NULL
due	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
these	NULL
holes	NULL
in	NULL
the	NULL
membrane	NULL
,	NULL
which	NULL
enables	NULL
the	NULL
trypan	NULL
blue	NULL
to	NULL
penetrate	NULL
into	NULL
the	NULL
cytoplasm	NULL
.	NULL

The	NULL
surface	NULL
membrane	NULL
alterations	NULL
seem	NULL
to	NULL
be	NULL
specific	NULL
for	NULL
the	NULL
affected	NULL
cells	NULL
since	NULL
neither	NULL
unaffected	NULL
lymphocytes	NULL
nor	NULL
monocytes	NULL
lost	NULL
their	NULL
characteristic	NULL
surface	NULL
structure	NULL
after	NULL
incubation	NULL
with	NULL
cortisol	NULL
(	NULL
Fig	NULL
.	NULL

18	NULL
)	NULL
.	NULL

Specificity	NULL
of	NULL
GC	NULL
Activity	NULL
through	NULL
Interaction	NULL
of	NULL
the	NULL
Cytoplasmic	NULL
Receptors	NULL
.	NULL

In	NULL
order	NULL
to	NULL
demonstrate	NULL
the	NULL
specific	NULL
interaction	NULL
between	NULL
cortisol	NULL
and	NULL
cytoplasmic	NULL
receptors	NULL
as	NULL
one	NULL
of	NULL
the	NULL
initial	NULL
stages	NULL
in	NULL
the	NULL
GC-induced	NULL
lysis	NULL
of	NULL
the	NULL
CLL	NULL
cells	NULL
,	NULL
we	NULL
tried	NULL
to	NULL
inhibit	NULL
this	NULL
interaction	NULL
by	NULL
competitive	NULL
inhibitors	NULL
of	NULL
steroid	NULL
nature	NULL
which	NULL
do	NULL
not	NULL
cause	NULL
lysis	NULL
.	NULL

Such	NULL
possible	NULL
inhibitors	NULL
are	NULL
progesterone	NULL
and	NULL
cortexolone	NULL
.	NULL

The	NULL
inhibition	NULL
experiment	NULL
could	NULL
not	NULL
be	NULL
performed	NULL
by	NULL
studying	NULL
lysis	NULL
following	NULL
prolonged	NULL
incubation	NULL
of	NULL
cells	NULL
with	NULL
cortisol	NULL
(	NULL
2	NULL
x	NULL
10~	NULL
``	NULL
m	NULL
)	NULL
and	NULL
excess	NULL
inhibitors	NULL
(	NULL
10~*	NULL
m	NULL
)	NULL
,	NULL
since	NULL
such	NULL
concentrations	NULL
of	NULL
progesterone	NULL
and	NULL
cortexolone	NULL
lyse	NULL
lymphocytes	NULL
nonspecifically	NULL
by	NULL
alteration	NULL
of	NULL
the	NULL
cell	NULL
membrane	NULL
.	NULL

Thus	NULL
,	NULL
GC	NULL
such	NULL
as	NULL
cortisol	NULL
or	NULL
dexamethasone	NULL
specifically	NULL
kill	NULL
CLL	NULL
cells	NULL
without	NULL
affecting	NULL
normat	NULL
pe-	NULL
APRIL	NULL
1982	NULL
Chart	NULL
3	NULL
.	NULL

Mean	NULL
sensitivity	NULL
of	NULL
CLL	NULL
(	NULL
8	NULL
subjects	NULL
)	NULL
and	NULL
normal	NULL
(	NULL
10	NULL
subjects	NULL
)	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBL	NULL
)	NULL
to	NULL
in	NULL
vitro	NULL
steroid-induced	NULL
cytolysis	NULL
.	NULL

O	NULL
,	NULL
cortisol	NULL
;	NULL
@	NULL
,	NULL
dexamethasone	NULL
;	NULL
C	NULL
,	NULL
progesterone	NULL
;	NULL
A	NULL
,	NULL
cortexolone	NULL
;	NULL
lll	NULL
,	NULL
Sa-dinydrotestosterone	NULL
;	NULL
A	NULL
,	NULL
estradiol	NULL
.	NULL

Table	NULL
2	NULL
Inhibition	NULL
of	NULL
cortisol-induced	NULL
cytolysis	NULL
by	NULL
cortexolone	NULL
Drug	NULL
content	NULL
%	NULL
of	NULL
lysis	NULL
Cortisol	NULL
(	NULL
2	NULL
x	NULL
10~	NULL
``	NULL
m	NULL
)	NULL
58	NULL
£	NULL
#	NULL
1.2°	NULL
Cortexolone	NULL
(	NULL
10~*	NULL
m	NULL
)	NULL
8.7	NULL
+	NULL
4.9	NULL
Cortisol	NULL
(	NULL
2	NULL
x	NULL
10~	NULL
``	NULL
m	NULL
)	NULL
+	NULL
cortexolone	NULL
(	NULL
10~*	NULL
m	NULL
)	NULL
11.2	NULL
+	NULL
5.1	NULL
``	NULL
Mean	NULL
+	NULL
S.E	NULL
.	NULL

of	NULL
experiments	NULL
performed	NULL
with	NULL
CLL	NULL
cells	NULL
from	NULL
8	NULL
different	NULL
patients	NULL
.	NULL

ripheral	NULL
blood	NULL
lymphocytes	NULL
whereas	NULL
prolonged	NULL
incubation	NULL
with	NULL
progesterone	NULL
or	NULL
cortexolone	NULL
caused	NULL
the	NULL
lysis	NULL
of	NULL
normal	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
as	NULL
well	NULL
(	NULL
Chart	NULL
3	NULL
)	NULL
.	NULL

The	NULL
steroids	NULL
estradiol	NULL
and	NULL
Sa-dihydrotestosterone	NULL
,	NULL
which	NULL
do	NULL
not	NULL
intereact	NULL
with	NULL
the	NULL
cytoplasmic	NULL
receptors	NULL
,	NULL
fail	NULL
also	NULL
to	NULL
affect	NULL
the	NULL
viability	NULL
of	NULL
the	NULL
CLL	NULL
cells	NULL
at	NULL
10~	NULL
``	NULL
m.	NULL
Since	NULL
progesterone	NULL
was	NULL
found	NULL
to	NULL
exert	NULL
a	NULL
high	NULL
nonspecific	NULL
lysis	NULL
due	NULL
to	NULL
its	NULL
strong	NULL
lipophilic	NULL
affinity	NULL
,	NULL
only	NULL
cortexolone	NULL
was	NULL
utilized	NULL
as	NULL
a	NULL
competitive	NULL
inhibitor	NULL
.	NULL

Inhibitory	NULL
competition	NULL
experiments	NULL
were	NULL
performed	NULL
by	NULL
incubation	NULL
of	NULL
CLL	NULL
cells	NULL
with	NULL
cortexolone	NULL
(	NULL
10~*	NULL
m	NULL
)	NULL
for	NULL
30	NULL
min	NULL
and	NULL
administration	NULL
of	NULL
cortisol	NULL
(	NULL
2	NULL
x	NULL
107	NULL
``	NULL
m	NULL
)	NULL
for	NULL
additional	NULL
30	NULL
min	NULL
incubation	NULL
at	NULL
37°	NULL
.	NULL

Thereafter	NULL
,	NULL
the	NULL
steroids	NULL
were	NULL
removed	NULL
by	NULL
washing	NULL
in	NULL
order	NULL
to	NULL
avoid	NULL
a	NULL
nonspecific	NULL
lysis	NULL
by	NULL
cortexolone	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
further	NULL
incubated	NULL
for	NULL
6	NULL
hr	NULL
at	NULL
37°	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Table	NULL
2	NULL
,	NULL
in	NULL
such	NULL
conditions	NULL
,	NULL
coincubation	NULL
of	NULL
cells	NULL
with	NULL
cortisol	NULL
and	NULL
a	NULL
S-fold	NULL
excess	NULL
of	NULL
cortexolone	NULL
resulted	NULL
in	NULL
a	NULL
75	NULL
%	NULL
inhibition	NULL
of	NULL
cytolysis	NULL
observed	NULL
with	NULL
cortisol	NULL
alone	NULL
.	NULL

DISCUSSION	NULL
Until	NULL
now	NULL
,	NULL
most	NULL
of	NULL
the	NULL
information	NULL
concerning	NULL
GC-induced	NULL
1435	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1982	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

U.	NULL
Galili	NULL
et	NULL
al	NULL
.	NULL

lysis	NULL
of	NULL
lymphoid	NULL
cells	NULL
has	NULL
been	NULL
obtained	NULL
from	NULL
studies	NULL
on	NULL
cells	NULL
obtained	NULL
from	NULL
experimental	NULL
animals	NULL
,	NULL
such	NULL
as	NULL
mouse	NULL
and	NULL
rat	NULL
thymocytes	NULL
and	NULL
murine	NULL
lymphoma	NULL
cells	NULL
(	NULL
1	NULL
,	NULL
6	NULL
,	NULL
15	NULL
,	NULL
22	NULL
)	NULL
.	NULL

The	NULL
data	NULL
obtained	NULL
from	NULL
the	NULL
present	NULL
study	NULL
indicate	NULL
that	NULL
the	NULL
mechanism	NULL
of	NULL
GC-induced	NULL
lysis	NULL
of	NULL
CLL	NULL
cells	NULL
appears	NULL
to	NULL
be	NULL
in	NULL
accord	NULL
with	NULL
the	NULL
general	NULL
model	NULL
of	NULL
steroid	NULL
action	NULL
on	NULL
animal	NULL
cells	NULL
.	NULL

Incubation	NULL
of	NULL
CLL	NULL
cells	NULL
with	NULL
cortisol	NULL
at	NULL
4°	NULL
for	NULL
30	NULL
min	NULL
with	NULL
subsequent	NULL
removal	NULL
of	NULL
the	NULL
hormone	NULL
from	NULL
the	NULL
medium	NULL
resulted	NULL
in	NULL
the	NULL
same	NULL
extent	NULL
of	NULL
cell	NULL
lysis	NULL
observed	NULL
in	NULL
CLL	NULL
cells	NULL
which	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
hormone	NULL
at	NULL
37°	NULL
for	NULL
30	NULL
min	NULL
followed	NULL
by	NULL
subsequent	NULL
incubation	NULL
for	NULL
an	NULL
additional	NULL
8	NULL
hr	NULL
without	NULL
the	NULL
hormone	NULL
.	NULL

The	NULL
rapid	NULL
penetration	NULL
of	NULL
the	NULL
hormone	NULL
and	NULL
the	NULL
irreversibility	NULL
of	NULL
the	NULL
lytic	NULL
process	NULL
are	NULL
well	NULL
recognized	NULL
and	NULL
have	NULL
been	NULL
demonstrated	NULL
in	NULL
our	NULL
earlier	NULL
studies	NULL
(	NULL
12	NULL
)	NULL
,	NULL
where	NULL
5	NULL
min	NULL
of	NULL
incubation	NULL
of	NULL
CLL	NULL
cells	NULL
with	NULL
the	NULL
hormone	NULL
were	NULL
sufficient	NULL
to	NULL
induce	NULL
lysis	NULL
of	NULL
CLL	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
binding	NULL
of	NULL
GC	NULL
to	NULL
the	NULL
receptors	NULL
and	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
complex	NULL
which	NULL
is	NULL
temperature	NULL
independent	NULL
,	NULL
the	NULL
translocation	NULL
of	NULL
the	NULL
complex	NULL
into	NULL
the	NULL
nucleus	NULL
was	NULL
found	NULL
to	NULL
be	NULL
temperature	NULL
dependent	NULL
in	NULL
rat	NULL
thymocytes	NULL
and	NULL
does	NULL
not	NULL
occur	NULL
in	NULL
the	NULL
cold	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
latter	NULL
phenomenon	NULL
may	NULL
explain	NULL
why	NULL
cell	NULL
lysis	NULL
is	NULL
inhibited	NULL
at	NULL
4°	NULL
.	NULL

However	NULL
,	NULL
the	NULL
fact	NULL
that	NULL
cells	NULL
incubated	NULL
for	NULL
1	NULL
hr	NULL
at	NULL
37°	NULL
and	NULL
thereafter	NULL
at	NULL
4°	NULL
(	NULL
not	NULL
shown	NULL
in	NULL
results	NULL
)	NULL
were	NULL
not	NULL
lysed	NULL
indicates	NULL
that	NULL
there	NULL
are	NULL
additional	NULL
stages	NULL
in	NULL
the	NULL
lytic	NULL
process	NULL
which	NULL
are	NULL
in	NULL
fact	NULL
temperature	NULL
dependent	NULL
.	NULL

It	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
these	NULL
stages	NULL
include	NULL
transcription	NULL
of	NULL
the	NULL
gene	NULL
(	NULL
s	NULL
)	NULL
activated	NULL
by	NULL
the	NULL
steroid-receptor	NULL
complex	NULL
and	NULL
the	NULL
posttranscriptional	NULL
events	NULL
which	NULL
may	NULL
include	NULL
the	NULL
generation	NULL
of	NULL
``	NULL
lethal	NULL
``	NULL
products	NULL
or	NULL
activation	NULL
of	NULL
enzymes	NULL
causing	NULL
autolysis	NULL
.	NULL

Unlike	NULL
other	NULL
systems	NULL
involving	NULL
the	NULL
anabolic	NULL
effects	NULL
of	NULL
steroids	NULL
in	NULL
which	NULL
a	NULL
variety	NULL
of	NULL
gene	NULL
products	NULL
including	NULL
specific	NULL
mRNA	NULL
and	NULL
proteins	NULL
can	NULL
be	NULL
identified	NULL
in	NULL
exposed	NULL
cells	NULL
(	NULL
7	NULL
,	NULL
13	NULL
)	NULL
,	NULL
no	NULL
such	NULL
macromolecules	NULL
have	NULL
been	NULL
isolated	NULL
from	NULL
the	NULL
in	NULL
vitro	NULL
lytic	NULL
systems	NULL
in	NULL
animal	NULL
target	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
of	NULL
interest	NULL
to	NULL
note	NULL
that	NULL
the	NULL
use	NULL
of	NULL
metabolic	NULL
inhibitors	NULL
of	NULL
RNA	NULL
and	NULL
protein	NULL
synthesis	NULL
did	NULL
result	NULL
in	NULL
inhibition	NULL
of	NULL
GC-induced	NULL
lysis	NULL
in	NULL
the	NULL
rat	NULL
thymocyte	NULL
system	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
lysis	NULL
of	NULL
CLL	NULL
cells	NULL
obtained	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
actinomycin	NULL
D	NULL
,	NULL
cycloheximide	NULL
,	NULL
or	NULL
puromycin	NULL
suggests	NULL
that	NULL
the	NULL
killing	NULL
of	NULL
human	NULL
lymphoid	NULL
cells	NULL
induced	NULL
by	NULL
GC	NULL
is	NULL
also	NULL
mediated	NULL
through	NULL
the	NULL
production	NULL
of	NULL
specific	NULL
mRNA	NULL
and	NULL
proteins	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
the	NULL
inhibition	NULL
of	NULL
cell	NULL
lysis	NULL
by	NULL
these	NULL
agents	NULL
indicates	NULL
that	NULL
the	NULL
inhibitors	NULL
were	NULL
effective	NULL
only	NULL
if	NULL
they	NULL
were	NULL
added	NULL
to	NULL
the	NULL
cells	NULL
within	NULL
20	NULL
min	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
cortisol	NULL
.	NULL

From	NULL
the	NULL
above	NULL
data	NULL
,	NULL
it	NULL
can	NULL
be	NULL
assumed	NULL
that	NULL
the	NULL
duration	NULL
of	NULL
the	NULL
intracellular	NULL
process	NULL
,	NULL
from	NULL
the	NULL
time	NULL
of	NULL
steroid	NULL
penetration	NULL
into	NULL
the	NULL
cell	NULL
until	NULL
the	NULL
onset	NULL
of	NULL
the	NULL
first	NULL
posttranscriptional	NULL
events	NULL
,	NULL
is	NULL
no	NULL
more	NULL
than	NULL
30	NULL
min	NULL
,	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
cell	NULL
death	NULL
is	NULL
not	NULL
detected	NULL
until	NULL
6	NULL
hr	NULL
later	NULL
.	NULL

The	NULL
biological	NULL
effects	NULL
of	NULL
GC	NULL
studied	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
anabolic	NULL
systems	NULL
such	NULL
as	NULL
those	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
aminotransferases	NULL
in	NULL
hepatocytes	NULL
and	NULL
hepatoma	NULL
cells	NULL
were	NULL
also	NULL
found	NULL
to	NULL
initial	NULL
transcriptional	NULL
and	NULL
translational	NULL
events	NULL
rapidly	NULL
(	NULL
7	NULL
,	NULL
13	NULL
)	NULL
.	NULL

The	NULL
mRNAs	NULL
or	NULL
proteins	NULL
synthesized	NULL
in	NULL
these	NULL
hepatocytes	NULL
as	NULL
a	NULL
result	NULL
of	NULL
exposure	NULL
to	NULL
the	NULL
hormone	NULL
could	NULL
also	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
cells	NULL
within	NULL
10	NULL
to	NULL
20	NULL
min	NULL
after	NULL
the	NULL
administration	NULL
of	NULL
the	NULL
hormone	NULL
.	NULL

Similarly	NULL
,	NULL
studies	NULL
on	NULL
the	NULL
inhibition	NULL
of	NULL
GC-induced	NULL
lysis	NULL
of	NULL
rat	NULL
thymocytes	NULL
indicate	NULL
that	NULL
RNA	NULL
synthesis	NULL
occurred	NULL
within	NULL
several	NULL
min	NULL
after	NULL
administration	NULL
of	NULL
the	NULL
hormone	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
posttranscriptional	NULL
processes	NULL
leading	NULL
to	NULL
GC-induced	NULL
cell	NULL
death	NULL
are	NULL
still	NULL
not	NULL
clearly	NULL
understood	NULL
.	NULL

However	NULL
,	NULL
the	NULL
ultrastructural	NULL
studies	NULL
of	NULL
the	NULL
lytic	NULL
process	NULL
provide	NULL
some	NULL
clues	NULL
for	NULL
1436	NULL
the	NULL
understanding	NULL
of	NULL
these	NULL
events	NULL
.	NULL

The	NULL
initial	NULL
changes	NULL
,	NULL
detected	NULL
after	NULL
2	NULL
hr	NULL
of	NULL
incubation	NULL
of	NULL
the	NULL
affected	NULL
cells	NULL
with	NULL
the	NULL
hormone	NULL
,	NULL
were	NULL
found	NULL
in	NULL
the	NULL
cytoplasm	NULL
and	NULL
cell	NULL
membrane	NULL
,	NULL
while	NULL
the	NULL
nuclei	NULL
still	NULL
retained	NULL
their	NULL
original	NULL
shape	NULL
and	NULL
form	NULL
.	NULL

The	NULL
homogeneous	NULL
appearance	NULL
of	NULL
the	NULL
cytoplasm	NULL
and	NULL
distribution	NULL
of	NULL
the	NULL
ribosomes	NULL
may	NULL
be	NULL
indicative	NULL
of	NULL
an	NULL
early	NULL
disruption	NULL
of	NULL
the	NULL
cytoplasmic	NULL
compartmentalization	NULL
,	NULL
which	NULL
may	NULL
also	NULL
result	NULL
in	NULL
the	NULL
penetration	NULL
of	NULL
water	NULL
into	NULL
the	NULL
mitochondria	NULL
,	NULL
causing	NULL
them	NULL
to	NULL
become	NULL
swollen	NULL
.	NULL

At	NULL
the	NULL
same	NULL
time	NULL
,	NULL
the	NULL
cell	NULL
surface	NULL
loses	NULL
its	NULL
villous	NULL
structure	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
surface	NULL
membrane	NULL
structure	NULL
is	NULL
affected	NULL
.	NULL

The	NULL
cytoplasmic	NULL
changes	NULL
appear	NULL
to	NULL
precede	NULL
membrane	NULL
alterations	NULL
since	NULL
they	NULL
were	NULL
also	NULL
evident	NULL
in	NULL
cells	NULL
which	NULL
had	NULL
retained	NULL
their	NULL
surface	NULL
microvilli	NULL
.	NULL

It	NULL
is	NULL
also	NULL
worthwhile	NULL
recording	NULL
that	NULL
no	NULL
changes	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
cells	NULL
after	NULL
1	NULL
hr	NULL
of	NULL
incubation	NULL
with	NULL
cortisol	NULL
.	NULL

The	NULL
condensation	NULL
of	NULL
the	NULL
nuclear	NULL
chromatin	NULL
seen	NULL
after	NULL
4	NULL
hr	NULL
of	NULL
incubation	NULL
with	NULL
GC	NULL
seems	NULL
to	NULL
be	NULL
secondary	NULL
to	NULL
structural	NULL
alterations	NULL
in	NULL
the	NULL
cytoplasm	NULL
and	NULL
cell	NULL
surface	NULL
and	NULL
may	NULL
reflect	NULL
pyknosis	NULL
due	NULL
to	NULL
activation	NULL
of	NULL
nu-cleases	NULL
,	NULL
as	NULL
reported	NULL
in	NULL
the	NULL
murine	NULL
thymocyte	NULL
system	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Unlike	NULL
the	NULL
GC-induced	NULL
killing	NULL
of	NULL
murine	NULL
thymocytes	NULL
,	NULL
which	NULL
is	NULL
characterized	NULL
by	NULL
bursting	NULL
of	NULL
the	NULL
nuclear	NULL
chromatin	NULL
into	NULL
the	NULL
cytoplasm	NULL
(	NULL
4	NULL
)	NULL
,	NULL
the	NULL
nuclear	NULL
membrane	NULL
in	NULL
the	NULL
dying	NULL
human	NULL
CLL	NULL
cell	NULL
seems	NULL
to	NULL
remain	NULL
intact	NULL
even	NULL
in	NULL
cells	NULL
showing	NULL
large	NULL
holes	NULL
in	NULL
their	NULL
surface	NULL
membrane	NULL
.	NULL

The	NULL
ultrastructural	NULL
studies	NULL
suggest	NULL
that	NULL
cytoplasmic	NULL
changes	NULL
followed	NULL
by	NULL
surface	NULL
membrane	NULL
changes	NULL
are	NULL
among	NULL
the	NULL
first	NULL
posttranscriptional	NULL
events	NULL
of	NULL
GC-induced	NULL
lysis	NULL
,	NULL
while	NULL
the	NULL
typical	NULL
nuclear	NULL
pyknosis	NULL
seems	NULL
to	NULL
be	NULL
a	NULL
secondary	NULL
change	NULL
occurring	NULL
at	NULL
a	NULL
later	NULL
stage	NULL
.	NULL

A	NULL
detailed	NULL
study	NULL
of	NULL
enzyme	NULL
activities	NULL
initiated	NULL
in	NULL
the	NULL
first	NULL
30	NULL
to	NULL
120	NULL
min	NULL
of	NULL
incubation	NULL
with	NULL
cortisol	NULL
may	NULL
be	NULL
useful	NULL
in	NULL
the	NULL
clearer	NULL
understanding	NULL
of	NULL
the	NULL
morphological	NULL
changes	NULL
reported	NULL
here	NULL
.	NULL

In	NULL
light	NULL
of	NULL
the	NULL
fact	NULL
that	NULL
transcriptional	NULL
and	NULL
translational	NULL
processes	NULL
seem	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
GC-induced	NULL
cytolysis	NULL
,	NULL
it	NULL
is	NULL
indeed	NULL
possible	NULL
that	NULL
the	NULL
administration	NULL
of	NULL
drugs	NULL
known	NULL
to	NULL
block	NULL
such	NULL
metabolic	NULL
events	NULL
may	NULL
exert	NULL
an	NULL
antagonistic	NULL
effect	NULL
when	NULL
given	NULL
to	NULL
patients	NULL
together	NULL
with	NULL
GC	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
therapeutic	NULL
regimens	NULL
.	NULL

It	NULL
could	NULL
be	NULL
argued	NULL
that	NULL
the	NULL
lysis	NULL
observed	NULL
in	NULL
presence	NULL
of	NULL
2	NULL
x	NULL
10~	NULL
``	NULL
m	NULL
cortisol	NULL
may	NULL
be	NULL
a	NULL
result	NULL
of	NULL
a	NULL
nonspecific	NULL
in	NULL
vitro	NULL
membranal	NULL
effect	NULL
of	NULL
the	NULL
hormone	NULL
on	NULL
the	NULL
cells	NULL
studied	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Our	NULL
previous	NULL
studies	NULL
have	NULL
indicated	NULL
that	NULL
cortisol-induced	NULL
cytolysis	NULL
is	NULL
a	NULL
specific	NULL
effect	NULL
which	NULL
can	NULL
be	NULL
demonstrated	NULL
in	NULL
distinct	NULL
normal	NULL
lymphoid	NULL
subsets	NULL
.	NULL

Human	NULL
prothymocytes	NULL
and	NULL
immune	NULL
activated	NULL
T-cells	NULL
are	NULL
readily	NULL
killed	NULL
by	NULL
such	NULL
cortisol	NULL
concentrations	NULL
,	NULL
whereas	NULL
the	NULL
human	NULL
thymocytes	NULL
or	NULL
mature	NULL
T-cells	NULL
are	NULL
completely	NULL
resistant	NULL
to	NULL
lysis	NULL
even	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10~*	NULL
m	NULL
cortisol	NULL
(	NULL
8-12	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
suggested	NULL
also	NULL
that	NULL
the	NULL
GC	NULL
sensitivity	NULL
of	NULL
the	NULL
various	NULL
stages	NULL
in	NULL
the	NULL
normal	NULL
T-cell	NULL
ontogeny	NULL
is	NULL
dependent	NULL
on	NULL
certain	NULL
characteristics	NULL
of	NULL
the	NULL
particular	NULL
differentiation	NULL
stage	NULL
rather	NULL
than	NULL
the	NULL
level	NULL
of	NULL
cytoplasmic	NULL
steroid	NULL
receptors	NULL
and	NULL
may	NULL
reflect	NULL
a	NULL
regulatory	NULL
mechanism	NULL
controlling	NULL
the	NULL
extent	NULL
of	NULL
immune	NULL
response	NULL
through	NULL
alternated	NULL
levels	NULL
of	NULL
cortisol	NULL
secreted	NULL
by	NULL
the	NULL
adrenal	NULL
.	NULL

Specificity	NULL
of	NULL
cortisol-induced	NULL
lysis	NULL
has	NULL
also	NULL
been	NULL
found	NULL
with	NULL
leukemic	NULL
cells	NULL
.	NULL

CLL	NULL
cells	NULL
and	NULL
malignant	NULL
cells	NULL
from	NULL
some	NULL
of	NULL
the	NULL
ALL	NULL
patients	NULL
were	NULL
lysed	NULL
by	NULL
such	NULL
cortisol	NULL
concentrations	NULL
,	NULL
whereas	NULL
myeloid	NULL
leukemic	NULL
cells	NULL
and	NULL
ALL	NULL
cells	NULL
from	NULL
almost	NULL
one-half	NULL
of	NULL
the	NULL
patients	NULL
studied	NULL
were	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
hormone	NULL
even	NULL
at	NULL
the	NULL
superpharmacological	NULL
concentration	NULL
of	NULL
10~*	NULL
m	NULL
(	NULL
12	NULL
)	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
the	NULL
synthetic	NULL
GC	NULL
dexamethasone	NULL
elicits	NULL
cytolysis	NULL
to	NULL
a	NULL
degree	NULL
not	NULL
significantly	NULL
different	NULL
from	NULL
that	NULL
of	NULL
cortisol	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
seems	NULL
that	NULL
the	NULL
factors	NULL
conferring	NULL
dexa-	NULL
CANCER	NULL
RESEARCH	NULL
VOL	NULL
.	NULL

42	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1982	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

methasone	NULL
with	NULL
its	NULL
high	NULL
clinical	NULL
potency	NULL
(	NULL
high	NULL
affinity	NULL
to	NULL
cytoplasmic	NULL
receptors	NULL
and	NULL
prolonged	NULL
retention	NULL
in	NULL
the	NULL
circulation	NULL
)	NULL
do	NULL
not	NULL
affect	NULL
the	NULL
capacity	NULL
of	NULL
the	NULL
hormone	NULL
to	NULL
induce	NULL
cytolysis	NULL
in	NULL
the	NULL
in	NULL
vitro	NULL
system	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
cortisol	NULL
effect	NULL
was	NULL
demonstrated	NULL
also	NULL
morphologically	NULL
utilizing	NULL
SEM	NULL
.	NULL

While	NULL
the	NULL
CLL	NULL
lymphocytes	NULL
were	NULL
lysed	NULL
within	NULL
6	NULL
hr	NULL
of	NULL
incubation	NULL
with	NULL
cortisol	NULL
,	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
membranal	NULL
features	NULL
of	NULL
the	NULL
GC-resist-ant	NULL
monocytes	NULL
and	NULL
lymphocytes	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

18	NULL
)	NULL
.	NULL

The	NULL
electron	NULL
microscopic	NULL
studies	NULL
demonstrating	NULL
the	NULL
cytoplasmic	NULL
changes	NULL
in	NULL
cells	NULL
which	NULL
have	NULL
not	NULL
yet	NULL
lost	NULL
the	NULL
surface	NULL
microvilli	NULL
following	NULL
2	NULL
hr	NULL
of	NULL
incubation	NULL
with	NULL
cortisol	NULL
also	NULL
support	NULL
the	NULL
assumption	NULL
that	NULL
the	NULL
GC-induced	NULL
cytolysis	NULL
is	NULL
not	NULL
a	NULL
result	NULL
of	NULL
a	NULL
nonspecific	NULL
membranal	NULL
effect	NULL
of	NULL
the	NULL
hormone	NULL
but	NULL
rather	NULL
an	NULL
intracellular	NULL
specific	NULL
chain	NULL
of	NULL
events	NULL
.	NULL

The	NULL
irreversibility	NULL
of	NULL
the	NULL
lytic	NULL
process	NULL
following	NULL
pulse	NULL
exposure	NULL
of	NULL
the	NULL
sensitive	NULL
cells	NULL
to	NULL
cortisol	NULL
at	NULL
4°	NULL
or	NULL
37°	NULL
for	NULL
30	NULL
min	NULL
suggests	NULL
the	NULL
involvement	NULL
of	NULL
cytoplasmic	NULL
steroid	NULL
receptors	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
such	NULL
receptors	NULL
in	NULL
lysis	NULL
was	NULL
demonstrated	NULL
by	NULL
inhibition	NULL
of	NULL
the	NULL
killing	NULL
as	NULL
a	NULL
result	NULL
of	NULL
the	NULL
administration	NULL
of	NULL
a	NULL
5-fold	NULL
excess	NULL
of	NULL
cortexolone	NULL
.	NULL

This	NULL
steroid	NULL
is	NULL
known	NULL
also	NULL
to	NULL
compete	NULL
with	NULL
the	NULL
cortisol	NULL
in	NULL
binding	NULL
to	NULL
the	NULL
cytoplasmic	NULL
receptors	NULL
and	NULL
to	NULL
react	NULL
as	NULL
antagonist	NULL
in	NULL
the	NULL
GC-induced	NULL
lysis	NULL
in	NULL
rodents	NULL
such	NULL
as	NULL
mice	NULL
or	NULL
rats	NULL
(	NULL
5	NULL
,	NULL
16	NULL
,	NULL
17	NULL
,	NULL
29	NULL
)	NULL
.	NULL

It	NULL
is	NULL
not	NULL
clear	NULL
as	NULL
yet	NULL
if	NULL
the	NULL
cytolysis	NULL
exerted	NULL
by	NULL
another	NULL
known	NULL
antagonist	NULL
,	NULL
pro-gesterone	NULL
,	NULL
is	NULL
merely	NULL
a	NULL
result	NULL
of	NULL
its	NULL
high	NULL
lipophilic	NULL
affinity	NULL
which	NULL
alters	NULL
the	NULL
cell	NULL
membrane	NULL
surface	NULL
or	NULL
whether	NULL
this	NULL
hormone	NULL
acts	NULL
in	NULL
the	NULL
human	NULL
system	NULL
as	NULL
an	NULL
agonist	NULL
.	NULL

Such	NULL
a	NULL
possibility	NULL
was	NULL
suggested	NULL
previously	NULL
by	NULL
Homo	NULL
et	NULL
al	NULL
.	NULL

(	NULL
16	NULL
)	NULL
.	NULL

Works	NULL
on	NULL
the	NULL
effect	NULL
of	NULL
GC	NULL
on	NULL
the	NULL
in	NULL
vitro	NULL
viability	NULL
of	NULL
human	NULL
leukemic	NULL
lymphoid	NULL
cells	NULL
have	NULL
been	NULL
performed	NULL
recently	NULL
utilizing	NULL
the	NULL
human	NULL
lymphoblastoid	NULL
T-cell	NULL
line	NULL
CEM	NULL
(	NULL
14	NULL
,	NULL
23	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
indicated	NULL
that	NULL
incubation	NULL
with	NULL
10~®	NULL
m	NULL
dexamethasone	NULL
results	NULL
in	NULL
inhibition	NULL
of	NULL
growth	NULL
and	NULL
formation	NULL
of	NULL
colonies	NULL
in	NULL
agarose	NULL
and	NULL
loss	NULL
in	NULL
cell	NULL
viability	NULL
after	NULL
18	NULL
to	NULL
24	NULL
hr	NULL
,	NULL
due	NULL
to	NULL
arrest	NULL
of	NULL
cells	NULL
in	NULL
G	NULL
,	NULL
.	NULL

It	NULL
seems	NULL
that	NULL
this	NULL
phenomenon	NULL
is	NULL
different	NULL
from	NULL
the	NULL
GC-induced	NULL
lysis	NULL
described	NULL
in	NULL
the	NULL
present	NULL
work	NULL
,	NULL
since	NULL
the	NULL
GC-sensitive	NULL
CLL	NULL
cells	NULL
are	NULL
mostly	NULL
in	NULL
G	NULL
,	NULL
and	NULL
do	NULL
not	NULL
proliferate	NULL
or	NULL
clone	NULL
in	NULL
vitro	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
lysis	NULL
of	NULL
CLL	NULL
cells	NULL
is	NULL
already	NULL
apparent	NULL
within	NULL
6	NULL
hr	NULL
of	NULL
incubation	NULL
with	NULL
the	NULL
hormone	NULL
,	NULL
whereas	NULL
in	NULL
the	NULL
system	NULL
utilizing	NULL
CEM	NULL
cells	NULL
cell	NULL
death	NULL
was	NULL
observed	NULL
following	NULL
18	NULL
hr	NULL
of	NULL
incubation	NULL
.	NULL

The	NULL
method	NULL
described	NULL
here	NULL
and	NULL
in	NULL
our	NULL
previous	NULL
study	NULL
(	NULL
12	NULL
)	NULL
thus	NULL
enables	NULL
the	NULL
evaluation	NULL
of	NULL
the	NULL
GC	NULL
sensitivity	NULL
of	NULL
freshly	NULL
obtained	NULL
leukemic	NULL
cells	NULL
,	NULL
which	NULL
do	NULL
not	NULL
necessarily	NULL
proliferate	NULL
in	NULL
in	NULL
vitro	NULL
conditions	NULL
as	NULL
a	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
wish	NULL
to	NULL
thank	NULL
Dr.	NULL
Nurit	NULL
Kaiser	NULL
,	NULL
from	NULL
the	NULL
department	NULL
of	NULL
Endocrinology	NULL
at	NULL
the	NULL
Hadassah	NULL
Hospital	NULL
,	NULL
for	NULL
her	NULL
helpful	NULL
discussions	NULL
and	NULL
suggestions	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Baxter	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Harris	NULL
,	NULL
A.	NULL
W.	NULL
Mechanism	NULL
of	NULL
glucocorticoid	NULL
action	NULL
:	NULL
general	NULL
features	NULL
with	NULL
reference	NULL
to	NULL
steroid-mediated	NULL
immunosuppression	NULL
.	NULL

Transplant	NULL
.	NULL

Proc	NULL
.	NULL

,	NULL
7	NULL
:	NULL
55-65	NULL
,	NULL
1975	NULL
.	NULL

2	NULL
.	NULL

Claesson	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
and	NULL
Ropke	NULL
,	NULL
C.	NULL
Quantitative	NULL
studies	NULL
on	NULL
cortisol-induced	NULL
decay	NULL
of	NULL
lymphoid	NULL
cells	NULL
in	NULL
the	NULL
thymolymphatic	NULL
system	NULL
.	NULL

Acta	NULL
Pathol	NULL
.	NULL

Micro-biol	NULL
.	NULL

Scand	NULL
.	NULL

,	NULL
76	NULL
:	NULL
376-382	NULL
,	NULL
1969	NULL
.	NULL

3	NULL
.	NULL

Claman	NULL
,	NULL
H.	NULL
N.	NULL
Corticosteroids	NULL
and	NULL
lymphoid	NULL
cells	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
287	NULL
:	NULL
388-397	NULL
,	NULL
1972	NULL
.	NULL

APRIL	NULL
1982	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

GC	NULL
Cytolysis	NULL
of	NULL
Leukemic	NULL
Cells	NULL
.	NULL

Cowan	NULL
,	NULL
W.	NULL
K.	NULL
,	NULL
and	NULL
Sorenson	NULL
,	NULL
G.	NULL
D.	NULL
Electron	NULL
microscopic	NULL
observations	NULL
of	NULL
acute	NULL
thymic	NULL
involution	NULL
produced	NULL
by	NULL
hydrocortisone	NULL
.	NULL

Lab	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
13	NULL
:	NULL
353-370	NULL
,	NULL
1964.	NULL
.	NULL

Duncan	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Duncan	NULL
,	NULL
J.	NULL
R.	NULL
An	NULL
in	NULL
vivo	NULL
study	NULL
of	NULL
action	NULL
of	NULL
antiglucocor-	NULL
ticolds	NULL
on	NULL
thymus	NULL
weight	NULL
ratio	NULL
,	NULL
antibody	NULL
titer	NULL
and	NULL
adrenal-pituitary-hypo-thalamus	NULL
axis	NULL
.	NULL

J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

,	NULL
10	NULL
:	NULL
245-259	NULL
,	NULL
1979.	NULL
.	NULL

Edelman	NULL
,	NULL
I.	NULL
S.	NULL
Mechanism	NULL
of	NULL
action	NULL
of	NULL
steroid	NULL
hormones	NULL
.	NULL

J.	NULL
Steroid	NULL
Bio-	NULL
chem	NULL
.	NULL

,	NULL
6	NULL
:	NULL
147-159	NULL
,	NULL
1975.	NULL
.	NULL

Emest	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Feigelson	NULL
,	NULL
P.	NULL
Muitinumoral	NULL
control	NULL
of	NULL
tyrosine	NULL
aminotrans-	NULL
ferase	NULL
in	NULL
isolated	NULL
liver	NULL
cells	NULL
.	NULL

Monogr	NULL
.	NULL

Endocrinol	NULL
.	NULL

,	NULL
12	NULL
;	NULL
219-241	NULL
,	NULL
1979.	NULL
.	NULL

Galili	NULL
,	NULL
N.	NULL
,	NULL
Galili	NULL
,	NULL
U.	NULL
,	NULL
Klein	NULL
,	NULL
E.	NULL
,	NULL
Rosenthal	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Nordenskjotd	NULL
,	NULL
B	NULL
.	NULL

Human	NULL
T	NULL
lymphocytes	NULL
become	NULL
glucocorticoid	NULL
sensitive	NULL
upon	NULL
immune	NULL
activation	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
50	NULL
:	NULL
440-444	NULL
,	NULL
1980.	NULL
.	NULL

Galili	NULL
,	NULL
U.	NULL
,	NULL
Klein	NULL
,	NULL
E.	NULL
,	NULL
Klein	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Bal	NULL
,	NULL
|	NULL
.	NULL

S.	NULL
Activated	NULL
T	NULL
lymphocytes	NULL
in	NULL
infiltrates	NULL
and	NULL
draining	NULL
lymph	NULL
nodes	NULL
of	NULL
nasopharyngeal	NULL
carcinoma	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
,	NULL
25	NULL
:	NULL
85-89	NULL
,	NULL
1980	NULL
.	NULL

Galili	NULL
,	NULL
U.	NULL
,	NULL
Kiein	NULL
,	NULL
E.	NULL
,	NULL
Christiansson	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Biberfeld	NULL
,	NULL
P.	NULL
Lymphocytes	NULL
from	NULL
Hodgkin	NULL
's	NULL
biopsies	NULL
exhibit	NULL
:	NULL
stable	NULL
E	NULL
rosette	NULL
formation	NULL
,	NULL
natural	NULL
attachment	NULL
and	NULL
glucocorticoid	NULL
sensitivity	NULL
,	NULL
similar	NULL
to	NULL
immunoactivated	NULL
T	NULL
cells	NULL
.	NULL

Clin	NULL
.	NULL

Immunol	NULL
.	NULL

Immunopathol	NULL
.	NULL

,	NULL
16	NULL
:	NULL
173-179	NULL
,	NULL
1980	NULL
.	NULL

Galili	NULL
,	NULL
U.	NULL
,	NULL
Polliack	NULL
,	NULL
A.	NULL
,	NULL
Okon	NULL
,	NULL
E.	NULL
,	NULL
Leizerovitz	NULL
,	NULL
H.	NULL
,	NULL
Gamliel	NULL
,	NULL
H.	NULL
,	NULL
Korkesh	NULL
,	NULL
A.	NULL
,	NULL
Shenkar	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
and	NULL
Izak	NULL
,	NULL
G.	NULL
Human	NULL
prothymocytes	NULL
:	NULL
membrane	NULL
properties	NULL
,	NULL
differentiation	NULL
patterns	NULL
,	NULL
glucocorticoid	NULL
sensitivity	NULL
and	NULL
ultrastructural	NULL
fea-tures	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
152	NULL
;	NULL
796-810	NULL
,	NULL
1980	NULL
.	NULL

Galili	NULL
,	NULL
U.	NULL
,	NULL
Prokocimer	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Izak	NULL
,	NULL
G.	NULL
The	NULL
in	NULL
vitro	NULL
sensitivity	NULL
of	NULL
leukemic	NULL
and	NULL
normal	NULL
leukocytes	NULL
to	NULL
hydrocortisone	NULL
induced	NULL
cytolysis	NULL
.	NULL

Blood	NULL
,	NULL
56	NULL
:	NULL
1077-1081	NULL
,	NULL
1980	NULL
.	NULL

Granner	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
Thompson	NULL
,	NULL
E.	NULL
B.	NULL
,	NULL
and	NULL
Tomkins	NULL
,	NULL
G.	NULL
M.	NULL
Dexamethasone	NULL
phosphate-induced	NULL
synthesis	NULL
of	NULL
tyrosine	NULL
aminotransferase	NULL
in	NULL
hepatoma	NULL
tissue	NULL
culture	NULL
cells	NULL
.	NULL

Studies	NULL
of	NULL
the	NULL
early	NULL
phases	NULL
of	NULL
induction	NULL
and	NULL
of	NULL
the	NULL
steroid	NULL
requirement	NULL
for	NULL
maintenance	NULL
of	NULL
the	NULL
induced	NULL
rate	NULL
of	NULL
synthesis	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
245	NULL
:	NULL
1472-1478	NULL
,	NULL
1970	NULL
.	NULL

Harmon	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Norman	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Fowlkes	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
E.	NULL
B.	NULL
Dexamethasone	NULL
induces	NULL
irreversible	NULL
G	NULL
,	NULL
arrest	NULL
and	NULL
death	NULL
of	NULL
human	NULL
lymphoid	NULL
cell	NULL
line	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

,	NULL
98	NULL
:	NULL
267-278	NULL
,	NULL
1979	NULL
.	NULL

Harris	NULL
,	NULL
A.	NULL
W.	NULL
,	NULL
and	NULL
Baxter	NULL
,	NULL
J.	NULL
D.	NULL
Variations	NULL
in	NULL
cellular	NULL
sensitivity	NULL
to	NULL
glucocor-ticoids	NULL
:	NULL
observations	NULL
and	NULL
mechanisms	NULL
.	NULL

Monogr	NULL
.	NULL

Endocrinol	NULL
.	NULL

,	NULL
12	NULL
:	NULL
423-448	NULL
,	NULL
1979	NULL
.	NULL

Homo	NULL
,	NULL
F.	NULL
,	NULL
Picard	NULL
,	NULL
F.	NULL
,	NULL
Durant	NULL
,	NULL
S.	NULL
,	NULL
Gagne	NULL
,	NULL
D.	NULL
,	NULL
Simon	NULL
,	NULL
J.	NULL
,	NULL
Dardenne	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Duval	NULL
,	NULL
D.	NULL
Glucocorticoid	NULL
receptors	NULL
and	NULL
their	NULL
functions	NULL
in	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

,	NULL
12	NULL
:	NULL
433-443	NULL
,	NULL
1980	NULL
.	NULL

Kaiser	NULL
,	NULL
N.	NULL
,	NULL
Mayer	NULL
,	NULL
M.	NULL
,	NULL
Milholland	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Rosen	NULL
,	NULL
F.	NULL
Studies	NULL
on	NULL
the	NULL
antiglucocorticoid	NULL
action	NULL
of	NULL
progesterone	NULL
in	NULL
rat	NULL
thymocytes	NULL
:	NULL
early	NULL
in	NULL
vitro	NULL
effects	NULL
.	NULL

J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

,	NULL
10	NULL
:	NULL
379-386	NULL
,	NULL
1979	NULL
.	NULL

Kirkpatrick	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
Milholland	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Rosen	NULL
,	NULL
F.	NULL
Stereospecific	NULL
glucocorticoid	NULL
binding	NULL
to	NULL
subcellular	NULL
fractions	NULL
of	NULL
the	NULL
sensitive	NULL
and	NULL
resistant	NULL
lympho-sarcoma	NULL
p	NULL
1798	NULL
.	NULL

Nature	NULL
(	NULL
New	NULL
Biol	NULL
.	NULL
)	NULL

,	NULL
232	NULL
:	NULL
216-218	NULL
,	NULL
1971	NULL
.	NULL

Martial	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Seeburg	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
and	NULL
Matulich	NULL
,	NULL
D.	NULL
T.	NULL
,	NULL
Goodman	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
and	NULL
Baxter	NULL
,	NULL
J.	NULL
D.	NULL
Regulation	NULL
of	NULL
growth	NULL
hormone	NULL
messenger	NULL
RNA	NULL
.	NULL

Monogr	NULL
.	NULL

Endocrinol	NULL
.	NULL

,	NULL
12	NULL
:	NULL
279-289	NULL
,	NULL
1979	NULL
.	NULL

Mayer	NULL
,	NULL
M.	NULL
,	NULL
Nir	NULL
,	NULL
S.	NULL
,	NULL
Mitholland	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Rosen	NULL
,	NULL
F.	NULL
Effect	NULL
of	NULL
temperature	NULL
on	NULL
glucocorticoid	NULL
uptake	NULL
and	NULL
glucocorticoid	NULL
receptor	NULL
translocation	NULL
in	NULL
rat	NULL
thymocytes	NULL
.	NULL

Arch	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

,	NULL
176	NULL
:	NULL
28-36	NULL
,	NULL
1976	NULL
.	NULL

Munck	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Brinck-Johnsen	NULL
,	NULL
T.	NULL
Specific	NULL
and	NULL
nonspecific	NULL
physicochemi-cal	NULL
interactions	NULL
of	NULL
glucocorticoids	NULL
and	NULL
related	NULL
steroids	NULL
with	NULL
rat	NULL
thymus	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
243	NULL
:	NULL
5556-5565	NULL
,	NULL
1968	NULL
.	NULL

Munck	NULL
,	NULL
A.	NULL
,	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Smith	NULL
,	NULL
K.	NULL
A.	NULL
Glucocorticoid	NULL
receptors	NULL
and	NULL
action	NULL
in	NULL
rat	NULL
thymocytes	NULL
and	NULL
immunologically	NULL
stimulated	NULL
human	NULL
peripheral	NULL
lymphocytes	NULL
.	NULL

Monogr	NULL
.	NULL

Endocrinol	NULL
.	NULL

,	NULL
12	NULL
:	NULL
341-355	NULL
,	NULL
1979	NULL
.	NULL

Norman	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
E.	NULL
B	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
glucocorticoid-sensitive	NULL
human	NULL
lymphoid	NULL
cell	NULL
line	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
37	NULL
:	NULL
3785-3791	NULL
,	NULL
1977	NULL
.	NULL

Polliack	NULL
,	NULL
A	NULL
.	NULL

Normal	NULL
transformed	NULL
and	NULL
leukemic	NULL
leukocytes	NULL
.	NULL

in	NULL
:	NULL
A.	NULL
Polliack	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
A	NULL
Scanning	NULL
Electron	NULL
Microscopy	NULL
Atlas	NULL
,	NULL
p.	NULL
5	NULL
.	NULL

Bertin	NULL
:	NULL
Springer-Verlag	NULL
,	NULL
1977	NULL
.	NULL

Rosenau	NULL
,	NULL
W.	NULL
,	NULL
Baxter	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Rousseau	NULL
,	NULL
G.	NULL
G.	NULL
,	NULL
and	NULL
Tomkins	NULL
,	NULL
G.	NULL
M.	NULL
Mechanism	NULL
of	NULL
resistance	NULL
to	NULL
steroids	NULL
:	NULL
glucocorticoid	NULL
receptor	NULL
defect	NULL
in	NULL
lymphoma	NULL
cells	NULL
.	NULL

Nat	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

,	NULL
237	NULL
:	NULL
20-23	NULL
,	NULL
1972	NULL
.	NULL

Schrek	NULL
,	NULL
R.	NULL
Cytotoxicity	NULL
of	NULL
adrenal	NULL
cortex	NULL
hormones	NULL
on	NULL
normal	NULL
and	NULL
malignant	NULL
lymphocytes	NULL
of	NULL
man	NULL
and	NULL
rat	NULL
.	NULL

Proc	NULL
.	NULL

Soc	NULL
.	NULL

Exp	NULL
.	NULL

Biol	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
108	NULL
:	NULL
328-332	NULL
,	NULL
1961	NULL
.	NULL

Sibley	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
and	NULL
Yamamoto	NULL
,	NULL
K.	NULL
R.	NULL
Mouse	NULL
lymphoma	NULL
cells	NULL
:	NULL
mechanisms	NULL
of	NULL
resistance	NULL
to	NULL
glucocorticoids	NULL
.	NULL

Monogr	NULL
.	NULL

Endocrinol	NULL
.	NULL

,	NULL
12	NULL
:	NULL
357-376	NULL
,	NULL
1979	NULL
.	NULL

Spilrr	NULL
,	NULL
A.	NULL
R.	NULL
A	NULL
low-viscosity	NULL
epoxy	NULL
resin	NULL
embedding	NULL
medium	NULL
for	NULL
electron	NULL
microscopy	NULL
.	NULL

J.	NULL
Ultrastruct	NULL
.	NULL

Res	NULL
.	NULL

,	NULL
26	NULL
:	NULL
31-37	NULL
,	NULL
1969	NULL
.	NULL

Turnell	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
Kaiser	NULL
,	NULL
N.	NULL
,	NULL
Milholland	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Rosen	NULL
,	NULL
F.	NULL
Glucocorticoid	NULL
receptors	NULL
in	NULL
rat	NULL
thymocytes	NULL
.	NULL

Interaction	NULL
with	NULL
the	NULL
antiglucocorticoid	NULL
cortexolone	NULL
and	NULL
mechanism	NULL
of	NULL
its	NULL
action	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
249	NULL
:	NULL
1133-1138	NULL
,	NULL
1974	NULL
.	NULL

Wyllie	NULL
,	NULL
A.	NULL
H.	NULL
Glucocorticoid-induced	NULL
thymocyte	NULL
apoptosis	NULL
is	NULL
associated	NULL
with	NULL
endogenous	NULL
endonuclease	NULL
activation	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
284	NULL
:	NULL
555-556	NULL
,	NULL
1980	NULL
.	NULL

1437	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1982	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

U.	NULL
Galili	NULL
et	NULL
al	NULL
.	NULL

Figs	NULL
.	NULL

1	NULL
to	NULL
4	NULL
.	NULL

TEM	NULL
and	NULL
SEM	NULL
of	NULL
CLL	NULL
lymphocytes	NULL
.	NULL

Note	NULL
the	NULL
marginated	NULL
nuclear	NULL
heterochromatin	NULL
,	NULL
elongated	NULL
mitochondria	NULL
,	NULL
clustered	NULL
ribosomes	NULL
,	NULL
and	NULL
villous	NULL
surfaces	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

Fig	NULL
.	NULL

1	NULL
,	NULL
x	NULL
6,400	NULL
;	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
x	NULL
9,500	NULL
;	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
x	NULL
5,300	NULL
;	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
x	NULL
15,000	NULL
.	NULL

Figs	NULL
.	NULL

5	NULL
to	NULL
8	NULL
.	NULL

TEM	NULL
and	NULL
SEM	NULL
of	NULL
CLL	NULL
lymphocytes	NULL
incubated	NULL
for	NULL
2	NULL
hr	NULL
with	NULL
2	NULL
x	NULL
10~°	NULL
m	NULL
cortisol	NULL
at	NULL
37°	NULL
.	NULL

Note	NULL
the	NULL
swollen	NULL
mitochondria	NULL
,	NULL
homogeneous	NULL
distribution	NULL
of	NULL
ribosomes	NULL
,	NULL
and	NULL
smooth	NULL
surfaces	NULL
of	NULL
some	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

Fig	NULL
.	NULL

5	NULL
,	NULL
x	NULL
8,600	NULL
;	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
x	NULL
14,700	NULL
;	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
x	NULL
7,000	NULL
;	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
x	NULL
13,000	NULL
.	NULL

Figs	NULL
.	NULL

9	NULL
to	NULL
12	NULL
.	NULL

TEM	NULL
and	NULL
SEM	NULL
of	NULL
CLL	NULL
lymphocytes	NULL
incubated	NULL
for	NULL
4	NULL
hr	NULL
with	NULL
2	NULL
x	NULL
10~	NULL
``	NULL
m	NULL
cortisol	NULL
at	NULL
37°	NULL
.	NULL

Note	NULL
the	NULL
smooth	NULL
but	NULL
porous	NULL
cell	NULL
membranes	NULL
,	NULL
peripheral	NULL
cytoplasmic	NULL
vacuoles	NULL
,	NULL
and	NULL
condensation	NULL
of	NULL
the	NULL
nuclear	NULL
chromatin	NULL
in	NULL
some	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

Fig	NULL
.	NULL

9	NULL
,	NULL
x	NULL
5,300	NULL
;	NULL
Fig	NULL
.	NULL

10	NULL
,	NULL
x	NULL
11,700	NULL
;	NULL
Fig	NULL
.	NULL

11	NULL
,	NULL
x	NULL
6,200	NULL
;	NULL
Fig	NULL
.	NULL

12	NULL
,	NULL
x	NULL
13,300	NULL
.	NULL

1438	NULL
CANCER	NULL
RESEARCH	NULL
VOL	NULL
.	NULL

42	NULL
Downloaded	NULL
from	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1982	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

GC	NULL
Cytolysis	NULL
of	NULL
Leukemic	NULL
Cells	NULL
APRIL	NULL
1982	NULL
1439	NULL
Downloaded	NULL
from	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1982	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

U.	NULL
Galili	NULL
et	NULL
al	NULL
.	NULL

Figs	NULL
.	NULL

13	NULL
to	NULL
18	NULL
.	NULL

TEM	NULL
and	NULL
SEM	NULL
of	NULL
CLL	NULL
lymphocytes	NULL
incubated	NULL
for	NULL
6	NULL
hr	NULL
with	NULL
2	NULL
x	NULL
107	NULL
``	NULL
m	NULL
cortisol	NULL
at	NULL
37°	NULL
.	NULL

Note	NULL
the	NULL
large	NULL
holes	NULL
in	NULL
the	NULL
cell	NULL
membrane	NULL
.	NULL

The	NULL
condensed	NULL
chromatin	NULL
is	NULL
preserved	NULL
within	NULL
the	NULL
nuclear	NULL
membrane	NULL
(	NULL
Fig	NULL
.	NULL

17	NULL
)	NULL
.	NULL

Some	NULL
of	NULL
the	NULL
unaffected	NULL
lymphocytes	NULL
(	NULL
L	NULL
)	NULL
and	NULL
monocytes	NULL
(	NULL
M	NULL
)	NULL
still	NULL
retain	NULL
their	NULL
original	NULL
surface	NULL
features	NULL
(	NULL
Fig	NULL
.	NULL

18	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

13	NULL
,	NULL
x	NULL
9,400	NULL
;	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
x	NULL
14,700	NULL
;	NULL
Fig	NULL
.	NULL

15	NULL
,	NULL
x	NULL
3,800	NULL
;	NULL
Fig	NULL
.	NULL

16	NULL
,	NULL
x	NULL
10,000	NULL
;	NULL
Fig	NULL
.	NULL

17	NULL
,	NULL
x	NULL
11,700	NULL
;	NULL
Fig	NULL
.	NULL

18	NULL
,	NULL
x	NULL
4,000	NULL
.	NULL

1440	NULL
CANCER	NULL
RESEARCH	NULL
VOL	NULL
.	NULL

42	NULL
Downloaded	NULL
from	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1982	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

AAGR	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
Cancer	NULL
Research	NULL
The	NULL
Journal	NULL
of	NULL
Cancer	NULL
Research	NULL
(	NULL
1916-1930	NULL
)	NULL
|	NULL
The	NULL
American	NULL
Journal	NULL
of	NULL
Cancer	NULL
(	NULL
1931-1940	NULL
)	NULL
Metabolic	NULL
and	NULL
Ultrastructural	NULL
Aspects	NULL
of	NULL
the	NULL
in	NULL
Vitro	NULL
Lysis	NULL
of	NULL
Chronic	NULL
Lymphocytic	NULL
Leukemia	NULL
Cells	NULL
by	NULL
Glucocorticoids	NULL
Uri	NULL
Galili	NULL
,	NULL
Rachel	NULL
Leizerowitz	NULL
,	NULL
Jan	NULL
Moreb	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Cancer	NULL
Res	NULL
1982	NULL
;	NULL
42:1433-1440	NULL
.	NULL

Updated	NULL
version	NULL
Access	NULL
the	NULL
most	NULL
recent	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//cancerres.aacrjournals.org/content/42/4/1	NULL
433	NULL
E-mail	NULL
alerts	NULL
Reprints	NULL
and	NULL
Subscriptions	NULL
Permissions	NULL
Sign	NULL
up	NULL
to	NULL
receive	NULL
free	NULL
email-alerts	NULL
related	NULL
to	NULL
this	NULL
article	NULL
or	NULL
journal	NULL
.	NULL

To	NULL
order	NULL
reprints	NULL
of	NULL
this	NULL
article	NULL
or	NULL
to	NULL
subscribe	NULL
to	NULL
the	NULL
journal	NULL
,	NULL
contact	NULL
the	NULL
AACR	NULL
Publications	NULL
Department	NULL
at	NULL
pubs	NULL
@	NULL
aacr.org	NULL
.	NULL

To	NULL
request	NULL
permission	NULL
to	NULL
re-use	NULL
all	NULL
or	NULL
part	NULL
of	NULL
this	NULL
article	NULL
,	NULL
use	NULL
this	NULL
link	NULL
http	NULL
:	NULL
//cancerres.aacrjournals.org/content/42/4/1	NULL
433	NULL
.	NULL

Click	NULL
on	NULL
``	NULL
Request	NULL
Permissions	NULL
``	NULL
which	NULL
will	NULL
take	NULL
you	NULL
to	NULL
the	NULL
Copyright	NULL
Clearance	NULL
Center	NULL
's	NULL
(	NULL
CCC	NULL
)	NULL
Rightslink	NULL
site	NULL
.	NULL

Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1982	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

